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 The myocardial Na
+
/H
+
 exchanger-1 (NHE1) plays a major role in regulation of 
intracellular pH and its upregulation has been implicated in increased ischemia-
reperfusion injury and other pathologies. Hydrogen peroxide (H2O2) is a major by-
product of reperfusion and is known to enhance NHE1 activity via ERK1/2 signaling. 
However, neither NHE1 activity nor its regulation by H2O2 has been examined in 
response to exercise. Therefore, we examined the effect of aerobic exercise training on 
intrinsic NHE1 activity, H2O2-mediated activation of NHE1, and H2O2-induced 
phosphorylation of ERK1/2 using isolated adult ventricular myocytes. Adult female 
Sprague-Dawley rats were randomly divided into sedentary (S, n=10) and exercise-
trained (E, n=8) groups. Heart weight:body weight and plantaris muscle cytochrome c 
oxidase activity was significantly greater by 6.8% and 1.9 fold, respectively, in E animals 
compared to S animals. NHE1 activity was determined in cells loaded with the pH 
fluoroprobe 2′,7′‑bis‑(2‑carboxyethyl)‑5‑(and‑6)‑carboxyfluorescein (BCECF). NHE1 
activity was 161% greater in E myocytes compared to S myocytes (0.57 ± 0.10 v 1.49 ± 
0.18 fmol/min), which is attributed to the 55% greater cell volume (22.2 ± 0.6 v 34.3 ± 
1.1 pL) and 48% greater buffering capacity (28.79 ± 0.72 v 42.65 ± 0.79 mM/pH unit) of 
E cells. Stimulation with H2O2 enhanced NHE1 activity in S and E but to a significantly 
lower level in E myocytes (1.55 v 0.64 fold). As assessed by Western blotting, H2O2 
stimulation also increased phosphorylation of ERK1/2. There was no difference in the 
density of H2O2-stimulated phosphorylation between S and E; however, E myocytes were 
 
 
observed to have significantly less total ERK1/2. No difference was observed in either 
cardiomyocyte NHE1 content or catalase and glutathione peroxidase activity. Our data 
indicate that aerobic exercise training increases NHE1 activity at physiological 
intracellular pH and attenuates the H2O2-mediated activation of NHE1 activity.  
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CHAPTER I 
INTRODUCTION 
 
Statement of Problem. 
Nearly 2,300 Americans die of cardiovascular diseases each day – one person 
every 38 seconds. The most common type of cardiovascular disease and the leading cause 
of death in America is coronary heart disease. Ischemia-reperfusion (IR) injury 
(commonly referred to as a heart attack) is the result of a coronary event and remains an 
important clinical problem following heart surgery (132). IR is the lack of blood flow and 
the subsequent return of blood flow to a tissue, which can result in secondary cell death. 
Chronic aerobic exercise stimulates the heart cell to change in a way that better protects it 
from the consequences of a heart attack and other major pathologies. Although exercise-
induced protection exists, the various mechanisms are not well understood. One 
candidate mechanism that involves heart cell death is the role of the sodium-hydrogen 
exchanger (NHE1). There is strong evidence that NHE1 plays a critical role in not only 
IR injury but also a number of pathologies including diabetes, hypertension, and 
pathological hypertrophy due to its role in intracellular Ca
2+
 overload, a primary factor of 
cell death. Increased expression and activity of NHE1 is tightly linked with greater IR 
injury and is consistently present in other cardiac pathologies (109). Furthermore, NHE1 
activity is regulated by specific proteins activated during IR; these proteins are termed 
ERK1/2. Conversely, inhibition and knock-out of NHE1 significantly reduces IR-induced 
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injury (207,208) and pathological hypertrophy (110). Thus, previous results indicate that 
NHE1 suppression is cardioprotective. We have shown that exercise training significantly 
reduces NHE1 expression in heart muscle (67); however, it is not yet known whether this 
change has a role in exercise-induced cardioprotection. Therefore, investigating the 
NHE1 mechanism in response to exercise training will advance the knowledge of 
exercise-induced cardioprotective mechanisms and our understanding of exercise as a 
clinically-relevant measure for heart attack injury prevention. The long-term goal of this 
research is to understand the mechanisms by which aerobic exercise leads to 
cardioprotection. The overall objective of this proposal is to investigate a possible 
cardioprotective mechanism conferred by exercise on adult rat heart cells against a free 
radical (H2O2) insult; an H2O2 insult represents the oxidative stress suffered in the cell 
during IR. Our central hypothesis is that exercise reduces myocardial cell death by 
decreasing NHE1 protein content and secondary Ca
2+
 overload. We base our 
hypothesis on our prior work demonstrating that aerobic exercise training can decrease 
cardiac NHE1 protein content (67) and reduce heart cell injury upon exposure to H2O2 
(191). Our approach will be to measure changes in NHE1 protein expression and 
activity, and concurrent changes in ERK1/2 regulation of NHE1 in rat myocardium 
following 5 weeks of aerobic exercise training. Isolated cardiomyocytes from the same 
area of myocardium will be stimulated by H2O2 to show the cardioprotective impact of 
changes in NHE1 following exercise training, which will be revealed by the amount of 
intracellular Ca
2+
 overload and the extent of cell death. Our rationale for this approach is 
that H2O2 activates ERK1/2, which activates NHE1; increased NHE1 activity leads to 
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cell death through intracellular Ca
2+
 overload and increased free radical production – two 
major contributors to IR-induced cell death. Upon completion of this work, our 
expectation is that we will be able to demonstrate the relationship between exercise 
training, NHE1, and H2O2 insult, which in turn will enhance our knowledge of the role of 
aerobic exercise training in generating protective mechanisms. 
Aims and Hypotheses. 
We will test our overall hypothesis by pursuing the following aims.  
Aim 1: To determine the extent of change in NHE1 protein expression and 
activity induced by a 5-week aerobic exercise training program.  
Working hypotheses: in response to chronic aerobic exercise training 1) NHE1 
protein expression will decrease, 2) basal and H2O2-induced increase in ERK1/2 activity 
will not change, and 3) basal and H2O2-induced increase in NHE1 activity will decrease 
in a manner proportional to the decrease in expression.  
Aim 2: To determine the effect of exercise training on Ca
2+
 overload and 
myocardial apoptosis in response to an H2O2 insult.  
Working hypotheses: chronic aerobic exercise training will 1) decrease H2O2-
induced Ca
2+
 overload and 2) attenuate the H2O2-mediated activation of the cell death 
effector caspase-3. 
Given the severity of coronary heart disease and its resulting IR injury, 
identifying protective mechanisms against this insult is necessary to improve treatments 
that will prevent cell death. This work is innovative in that it will be the first to examine 
aerobic exercise-induced downregulation of NHE1 as a natural cardioprotection. 
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Ultimately our goal is to improve the health and well being of those at risk for a heart 
attack and cardiovascular disease through cardioprotective exercise.   
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CHAPTER II  
REVIEW OF THE LITERATURE 
 
 
Cardiovascular disease is a major source of IR injury. 
Nearly 2,300 Americans die of cardiovascular diseases each day – one person 
every 38 seconds (1). Coronary heart disease is the most common type of heart disease 
and the leading cause of death in America. The result of a coronary event, and still a 
clinical problem following heart surgery, is ischemia-reperfusion (IR) injury (132). This 
two part cellular event results in marked damage to downstream tissue. The ischemic 
phase represents when blood flow to an area of tissue significantly decreases or stops, 
markedly reducing ATP production by usual aerobic means; the rapid decline in energy 
inhibits specific ATP-dependent membrane proteins leading to intracellular ion 
imbalances, and shifts ATP production toward anaerobic glycolysis, which can result in 
decreased intracellular pH (pHi). The lower pHi alters enzyme activity and causes 
secondary ion changes. Moreover, most of the damage typically representing IR injury 
occurs during the reperfusion phase when blood flow is re-introduced to the area of 
tissue. The presented oxygen in combination with other cellular factors, some newly 
produced during ischemia, creates an environment well suited for cell damage, cell death, 
and arrhythmias – all of which are common developments preceding major declines in 
heart performance. 
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NHE1 is a critical element of IR injury.  
The sodium-hydrogen exchanger-1 (NHE1) is an essential regulator of pHi and 
has been implicated as a critical element of IR injury and other cardiac pathologies. 
During ischemia, the low oxygen saturation severely reduces the ability of oxidative 
phosphorylation to produce ATP, which switches energy production to anaerobic 
glycolysis. As glycolysis struggles to provide proper ATP levels, intracellular H
+
 (H
+
i) 
concentration rises and ATP-sensitive proteins are inhibited. The inhibition of these 
proteins, specifically Na
+
/K
+
 ATPase (NK ATPase), results in intracellular Na
+
 (Na
+
i) 
accumulation. Upon reperfusion, NHE1 acts as a primary source to the growing Na
+
i pool 
as it attempts to regulate the glycolysis-induced decline in pHi by extruding one H
+
i in 
exchange for one extracellular Na
+
 (213). The accumulation of Na
+
i activates the 
sarcolemmal Na
+
/Ca
2+
 exchanger (NCX) leading to intracellular Ca
2+ 
(Ca
2+
i) overload, 
which causes damaging effects such as cell death, contracture, and arrhythmias (73) (73). 
Additionally, the Ca
2+
i
 
imbalance produces oxidative stress that contributes to these 
detrimental effects (154). The accumulation of both Na
+
i and Ca
2+
i beyond the normal 
range has harmful consequences on the cell. Ca
2+
 accumulation activates proteases (i.e. 
calpain) that can degrade regulatory elements (i.e. sarco-endoplasmic reticulum Ca
2+
 
ATPase (SERCA2a)) that perpetuate the Ca
2+
i imbalance (77). Moreover, the high Ca
2+
i 
can overwhelm the mitochondria, which causes swelling of the organelle and initiation of 
the mitochondrial-mediated cell death cascade (199). On the other hand, Na
+
i can disrupt 
necessary Ca
2+
 entry into the mitochondria via the mitochondrial NCX. A lack of Ca
2+
 in 
the mitochondria slows Krebs Cycle dehydrogenase activity and subsequent NADH 
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production, which attenuates ATP production and glutathione restoration; decreased 
glutathione levels allows for greater ROS formation, which augments cellular damage 
(115). These cellular events clearly illustrate the critical involvement of NHE1 in IR 
injury, and support that altering NHE1 in such a way that leads to a reduction in cell 
damage following IR (i.e. possibly via its downregulation) could be a potential 
mechanism for cardioprotection.  
 
Changes in NHE1 protein content and activity affect severity of injury. 
Increased expression and activity of the NHE1 protein, associated with a number 
of pathologies including diabetes, hypertension, and pathological hypertrophy (109), 
results in greater IR-induced damage and eventual cell death. Because NHE1 is 
upregulated in many pathological settings, transgenic mice have been used to help 
determine the effects of this upregulation in relation to IR and hypertrophy, and to 
establish whether an increase in either expression, activity, or both play a central role in 
the effects.  
NHE1 genetic manipulation has consistently proven to increase NHE1 levels by 
2-fold or greater compared to controls (9,44,98). Imahashi et al. used a α-MHC promoter 
to create a N-line and a K-line. The N-line contained an overexpression of wild-type 
(WT) NHE1, while the K-line was overactive due to point mutations on the calmodulin-
binding domain that produced an alkaline shift to the working pH of NHE1 (98); NHE1 
is normally inactive near its set-point of pH 7.4 (46). No effect on basal contractile or 
metabolic function was observed following genetic manipulation; indices of contractile 
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function were LVDP, HR and +dP/dt, and indices of metabolic function were [ATP], 
[PCr], and pHi. During 20 min of ischemia, neither pHi nor Nai were different among 
groups, which included wild-type, N-line, and K-line mice.  After reperfusion, transgenic 
mice had an improved rate-pressure product (RPP) – heart rate X systolic blood pressure. 
The drawn conclusion was an overexpression of NHE1 above endogenous levels was not 
harmful at rest or in response to IR. This idea was supported by Baczko et al. who used 
WT and N-line (overexpressed NHE1) mice and showed no change in basal contractile 
function observed in isolated myocytes. Moreover, after metabolic inhibition (using 
NaCN and 2-deoxyglucose) and recovery, N-line mice had increased fractional cell 
shortening and diastolic Ca
2+
i levels. These increases were speculated to be the cause of 
the enhanced contractility following IR, as seen by Imahashi et al (98). 
These mouse genetic studies were somewhat counterintuitive compared to the 
many NHE1 inhibition studies that had demonstrated cardiac protection in rats 
(169,185,199,210,225). Thus, Cook et al. thought examining the systemic cellular effects 
of the genetic manipulation of NHE1 on other cellular components was necessary. To 
date, no peripheral changes to other ion regulatory channels had been observed, such as 
NK ATPase, SERCA, NCX (98,143), NBC (Na-bicarbonate cotransporter), AE3 (anion 
exchanger type 3) (98), and calsequestrin (143). Again, overexpression of NHE1 
provided protection against 20 or 30 min of ischemia and 120 min of reperfusion in 3-4 
month old mice. Interestingly, this age point presented an increase of incomplete NHE1 
precursors in the ER, as was an increase in ER stress proteins – presumably from an 
unfolded protein response. The upregulation of ER stress proteins calreticulin and protein 
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disulfide isomerase was later corroborated by multiple studies (108,139). Were these 
unintended changes of genetic manipulation? Were these NHE1-independent effects 
responsible for the protection initially prescribed to NHE1 overexpression? Martindale et 
al. showed that the unfolded protein response activates the upregulation of ER stress 
proteins, which reduce IR injury (129) and could have contributed to the observed 
protection. Possibly even more interesting was the mortality observed with aging in the 
transgenics. At 8 months, a dramatic separation of survival curves existed (44,139). At 12 
months, there was an increase in apoptosis in left ventricular myocardium compared to 
wild-type animals. In support of this, another transgenic mouse model presented with 
disrupted ER function and increased left ventricular apoptosis, implicating unrecovered 
ER stress as a cause of pathology (88). At 15 months, 90% of transgenic mice were dead, 
whereas 95% of WT mice were alive (44). In light of these findings, the altered Ca
2+
i 
handling, initially seen in the genetic lines as a mechanism providing contractile benefits, 
could be viewed as a result of ER stress and as another contributor to the heart failure 
phenotype (9). To that end, the discovery of ER stress protein upregulation caused the 
focus of transgenic NHE1 overexpression to shift away from mechanisms of IR 
protection to how overexpression produced the pathological phenotype. 
Cardiac hypertrophy and heart failure were the resultant phenotype of a study 
using mice with hyperactive NHE1 (K-line) (143). This study helped to elucidate the 
mechanism behind early-onset hypertrophy. An increase in the calcineurin-NFAT 
pathway was observed, which led to the speculation that NHE1 overexpression altered 
the expression of hypertrophy-associated genes (143). Again, was there a difference 
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between WT NHE1 and hyperactive NHE1 overexpression? Both WT overexpression 
and hyperactive NHE1 significantly changed the expression of genes associated with 
cardiac hypertrophy, necrosis/cell death, and infarction; however, the greatest response 
was from mice with hyperactive NHE1 (216). In fact, Mraiche et al. showed activity was 
necessary to induce cardiac hypertrophy in mice by separating the effect of the two 
transgenes (139). Mraiche et al. used point mutations on the C-terminal to show that the 
NHE1 activity was necessary for more severe effects of NHE1 overexpression, as K-line 
(hyperactive NHE1) mice displayed greater heart weights and performed significantly 
more poorly in a treadmill test compared to both N-line and control mice. This group also 
noticed that the effects of Nakamura et al. were more drastic than those of Cook et al. and 
attributed it to NHE1 activity, since Nakamura deleted a large piece of the C-terminal 
(amino acids 637-656) to create a hyperactive NHE1, whereas Cook et al. simply 
overexpressed the WT NHE1. The mice with WT overexpression took longer to present 
major pathology than those with hyperactive NHE1. This information aligns nicely with 
the fact that human hearts with chronic end-stage heart failure did not have greater NHE1 
content compared to unused donor hearts, but instead had NHE-1 proteins with increased 
activity (219).  
The transgenic mouse initially presented controversy over the effect of NHE1 
overexpression; the protein was upregulated as in pathological conditions, yet was 
providing protection during IR. The genetic manipulation was uncovered to be the 
ultimate precursor of protection as an increase in unfolded NHE1 in the ER produced an 
upregulation of ER stress proteins and subsequent IR protection (9,129). Still, more work 
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should be performed to clarify these results, such as inhibiting ER stress proteins to 
observe whether protection remains. The transgenic mouse model is definitely useful for 
delineating the mechanisms behind NHE1-induced hypertrophy; however, the abundance 
of literature displaying IR protection conferred by NHE1 inhibition (as discussed below) 
trumps the evidence suggesting that NHE1 upregulation is a cell-mediated protective 
mechanism. The increased NHE1 present in diseased myocardium is attributed to a 
chronic stress, not ordinarily seen in healthy myocardium, and is most likely a response 
by the cell to better regulate pHi in the face of altered substrate metabolism. 
Many NHE1 inhibitors have been synthesized in order to elucidate the role of 
NHE1 in IR cardioprotection. Cariporide is the most well-known and most-used NHE1 
inhibitor (48,63,132,134,170,179,199,225); though, in recent years, many new inhibitors 
have been made in hopes of providing greater organ specificity and potency (114). 
Regardless of the specific inhibitor used, inhibition of the NHE1 has resulted in 
protection against IR injury (106,134). During and following IR, protection has been 
indicated by decreased release of creatine kinase (48,147) and lactate dehydrogenase 
(48,106,147,225) from the cell, improved recovery of left ventricular end-diastolic 
pressure (41,160), reduced infarct size (119,134,147,167), improved coronary flow 
(41,225), and decreased cytosolic and/or mitochondrial Ca
2+
 overload 
(48,106,174,199,207). Furthermore, NHE1 inhibition has attenuated caspase-3 activation, 
Na
+
i and Ca
2+
i accumulation, mitochondrial Ca
2+
 overload and membrane potential 
following an H2O2 insult (195). Additionally, NHE1 inhibition results in decreased H
+
 
extrusion from the cytosol leading to a maintained acidic pHi, which is associated with 
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protection from mitochondrial permeability transition pore (MPTP) opening. The MPTP, 
a pore crossing the mitochondrial membranes that releases signals to the cell that activate 
cell death, is inhibited as the cytosolic pH drops below 7 (87). In sum, the cytoprotective 
effect of NHE1 inhibitors in basic models is quite evident; unfortunately, clinical trials 
have failed to garner a similar reputation. 
Only cariporide has been able to display beneficial effects in human patients; both 
zoniporide and eniporide failed to show significant differences regarding clinical 
outcomes (i.e. death, myocardial infarction, and arrhythmia) in non-cardiac vascular 
surgeries (70), thrombolytic therapies, and primary angioplasties (221). In 2000, 
cariporide decreased CK and LDH release and improved ejection fraction and end-
systolic volume in patients with acute myocardial infarction (MI) treated with 
percutaneous transluminal coronary angioplasty (172). That same year, cariporide was 
deemed safe when given to a wide range of at-risk clinical situations; unfortunately, 
protection was limited to patients undergoing bypass surgery (196). Subsequent clinical 
trials noted protection from cariporide in patients undergoing high-risk coronary artery 
bypass graft (CABG) surgery. One such trial, GUARd During Ischemia Against Necrosis 
(GUARDIAN), infused cariporide 1 hr before surgery and every 8 hrs for 2-7 days 
following surgery. A 120 mg dose reduced the risk of MI on post-operative day 1 and 
decreased MI and all-cause mortality at day 36 (24). The first phase III trial, EXchange 
inhibition to Prevent coronary Events in acute cardiac conDITIONs (EXPEDITION), to 
use cariporide on CABG patients saw that at 5 days post-operation the incidence of death 
or MI significantly decreased 20.3% compared to the placebo of 16.6%. Unfortunately, 
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cerebrovascular events associated with cariporide caused mortality to significantly 
increase 2.2% compared to the placebo of 1.5%. Additionally, no significance was 
observed at 6 months (131). Thus, NHE1 inhibition through pharmacological inhibitors 
does hold therapeutic promise, but more work needs to be completed to examine whether 
a more specific inhibitor would be more effective or if inhibition of regulators of NHE1 
are critical to protection. Nonetheless, basic models have shown that NHE1 inhibition 
results in a decrease in Ca
2+
i overload, inhibition of MPTP opening, and a decrease in 
apoptosis (199,225) ultimately leading to cardioprotection. Because human clinical trials 
using NHE1 inhibitors have not produced their anticipated outcomes, the rationale to 
explore alternative approaches that provide IR injury protection through NHE1 is 
strengthened. 
The transgenic overexpression data suggest that activation of the proteins 
regulating NHE1 activity (and not the protein itself) may be more critical to producing 
the harmful effects mediated by NHE1, since the hyperactive NHE1 was more closely 
associated with the IR protection (98,140) and cardiac hypertrophy (139) in this model. 
Additionally, post-translational regulation may likely play a role (219). Therefore, 
determining the roles of specific NHE1 regulators could be the key to future clinical 
therapies.  
 
The main regulators of NHE1 activity are ERK1/2. 
The mitogen-activated protein kinases (MAPK) are cell signaling proteins 
involved in the regulation of cell proliferation, differentiation, metabolism, motility, 
14 
 
survival and apoptosis. The MAPKs are divided into subfamilies: extracellular signal-
regulated kinases (ERK1/2), c-jun NH2-terminal kinases (JNK), p38 kinase, and big 
MAPK (BMK or ERK5). These proteins are activated by dual phosphorylation of a Thr-
X-Tyr motif in a regulatory loop, where X is either Gly, Pro, or Glu. Activation typically 
occurs from a proximal cascade of proteins: MAPK kinase kinase  MAPK kinase  
MAPK. The MAPK can then use ATP to phosphorylate its target protein on Ser or Thr 
residues. The MAPK subfamilies have a great deal of specificity based on activating 
mitogens and upstream and downstream modulators; however, subfamilies also can share 
upstream and downstream activators, which allows for potential cross-talk and feedback 
between them (168). Specifically, ERK1/2 is a pair of proteins with the molecular 
weights of 44 kD and 42 kD for ERK1 and ERK2, respectively. They are 83% identical 
in homology, but are not completely redundant in action. Both assist in regulation of cell 
cycle progression, proliferation, transcription, differentiation, senescence, cell death, and 
cell adhesion – just to name a few actions – through their ability to phosphorylate over 
100 possible substrates in the cytoplasm or nucleus, including transcription factors (220). 
ERK1/2’s major role in cardiovascular disease highlights why understanding the response 
of ERK1/2 to exercise and its putative role in exercise-induced cardioprotection can shed 
light on how to better manipulate the protein for improved therapies. Focus is given to 
ERK1/2, because it has proven to be a major regulator/activator of NHE1 activity in 
response to IR and ROS (137,173,185,210). In fact, p38 has no effect on NHE1 activity 
(185), JNK is not activated from short-term ischemia (210), and ERK5 has not been 
investigated.  
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The acidosis and ROS production that accompany IR are major mediators of IR-
induced ERK1/2 and NHE1 activation. The regulation of ERK1/2 on NHE1 has been 
observed in whole-hearts during episodes of IR (137), and in cardiomyocytes subjected to 
sustained acidosis (91,92) or H2O2 (173,185,210). In response to IR, in-gel kinase assays 
displayed that proteins with the molecular weights of 90, 44 and 42 kDa phosphorylated 
the carboxy-terminal 178 amino acids of NHE1; these molecular weights refer to p90rsk, 
ERK1 and ERK2, respectively. Western blots following immunoprecipitation showed 
that both ERK1/2 and NHE1 were phosphorylated. MEK is the MAPK kinase of ERK1/2 
and is inhibited by PD98059. PD98059 decreased the activation of ERK1/2 and NHE1, 
as observed by Western blots, and this corresponded to a significantly reduced rate of 
acid recovery and a lower steady state pH following recovery, supporting ERK1/2-
induced activation of NHE1 to be necessary for greater NHE1 activity (137).  
During IR, pHi levels can decrease to 5.5-6.0 after 30 min (187), which activates 
NHE1 because NHE1 is less active at basal pHi. NHE1 activity increases with increasing 
duration of acidosis in both neonatal and adult ventricular myocytes (92). The time 
course for acidosis-induced ERK1/2 activation is consistent with that of NHE1 (91,92); 
max activation occurs after 4 min of sustained acidosis (91). PD98059 or U-0126 (both 
inhibitors of MEK, the MAPK kinase of ERK1/2) abolished ERK1/2 activation by 
sustained acidosis, as did use of a dominant negative (DN) MEK (DN-D208A-MEK1) 
(91). In order to determine where on the C-terminal ERK1/2 was phosphorylating NHE1 
in response to acidosis, Malo et al. developed a group of human-NHE-1 mutants in AP-1 
cells that lacked an endogenous NHE1. The mutants had an alanine residue replace 
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different serine/threonine residues. The group with the S766A/S770A/S771A was not 
stimulated by acidosis. Following mutation of the individual amino acids, S770 and S771 
were deemed responsible for acidosis-induced ERK-dependent NHE1 activation 
(42,125). 
Hydrogen peroxide is a major free radical, and has been shown to activate 
ERK1/2 and induce NHE1 phosphorylation in a concentration- and time-dependent 
manner (173,210). Using a range of 1-200 uM H2O2 for 20 min on neonatal cardiac 
myocytes, Sabri et al. evaluated the dose-dependent activation of H2O2 on ERK2; ERK2 
was the main isozyme evaluated because it displayed detectable basal phosphorylation 
(173). Western blot analysis revealed that phosphorylation of ERK2 peaked with 50 uM 
H2O2, which is consistent with other research showing phosphorylation peaks above 10 
uM (185). Using 100 uM H2O2, Sabri et al. evaluated the time-dependent action of H2O2 
on ERK1/2. Activation was significant at 5 min of exposure and peaked at 20 min, which 
also is consistent with the time course of another study showing that >6 min is necessary 
for ERK1/2 activation (185). Furthermore, H2O2-induced NHE1 activation was blocked 
by PD98059 (173) and the antioxidant N-(2-mercaptopropionyl)-glycine (MPG) (81). 
These observations were corroborated in adult rat ventricular myocytes (210). Because 
many oxygen-derived free radicals exist in the IR environment, a series of experiments 
were used to determine if H2O2 truly was the ROS responsible for ERK2 activation. 
Catalase, presented to the cell 10 min before H2O2, completely abolished ERK2 
activation at all time points, suggesting H2O2 or 
–
OH was responsible for the activation. 
Additionally, neither presentation of superoxide generating systems (xanthine and 
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xanthine oxidase; LY83683 used in conjunction with normal cellular NADPH 
metabolism) nor pretreatment with SOD was able to significantly activate the MAPK. 
Together this evidence suggests that H2O2 mediates increases in NHE1 activity through 
ERK1/2. However, the exercise-induced alteration of ERK1/2 and its potential 
compensatory changes on NHE1 activity have not been investigated. 
Other mediators of NHE1 activity have been identified such as Akt (184), 
RhoA/p160ROCK (200,206), calmodulin (15,203), PKC (204), and ezrin, radixin, and 
moesin proteins (50). Most notably, the protein p90
rsk
 has been shown to be an effector of 
ERK1/2 and phosphorylate NHE1 on Ser703 independent from ERK1/2 (Haworth 2003; 
Cuello 2007); however, data suggests that p90
rsk
 is mostly dependent upon ERK1/2 
activation since inhibition with PD98059 (ERK1/2 inhibitor) blocked p90
rsk
 activation of 
NHE1 (136). Generally, research with other possible NHE1 regulators is inconclusive 
and not all have been studied in cardiomyocytes. Research surrounding ERK1/2 is more 
conclusive, has been performed extensively in cardiomyocytes, and has been better 
studied in conjunction with products of IR injury. Just as direct inhibition of the NHE1 
has proved beneficial at attenuating the ramifications of IR injury, so has inhibition of the 
ERK1/2 pathway. Many studies have demonstrated that by inhibiting ERK1/2 (with 
PD98059 on MEK), NHE1 activity is decreased or there is a reduced ability to recover 
from an acid load (92,137,169,173,186,206,210). Not only does this support the 
regulatory effect of ERK1/2 on NHE1 activity, but also justifies the importance of further 
examining how possible exercise-induced alterations in the ERK1/2 pathway may change 
NHE1 activity and the consequences of that change. Additionally, the fact that ERK1/2 
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has been deemed a critical factor in the reperfusion injury salvage kinase protein 
pathway, which is activated in ischemic preconditioning and postconditioning, supports 
the rationale for the need to investigate ERK1/2’s regulation of NHE1 as a mediator of 
exercise-induced cardioprotection. 
As of February 1, 2012, a PubMed search of “heart, exercise, MAPK” returned 14 
articles of which only one (examined below) truly detailed the effect of exercise on 
ERK1/2 alterations in the heart. A subsequent query of “heart, exercise, MAPK, ischemia 
reperfusion” returned zero articles. This demonstrates the lack of information between 
ERK1/2, exercise-induced cardioprotection, and pathways of IR injury. Iemitsu et al. 
performed a comprehensive study that observed changes in the basal phosphorylation and 
exercise-induced phosphorylation status of ERK1/2. Initially, rats were run acutely for 30 
min at 30 m/min to obtain a pre-training assessment of ERK1/2 during and post-exercise 
(97). In the untrained heart, ERK1/2 activation peaked at 15 min of exercise and 
remained significantly elevated by 2-fold at 30 min, suggesting during exercise ERK1/2 
is stimulated. Post-exercise, ERK1 remained elevated for 1 hr, suggesting ERK1/2 from 
sedentary rats is sensitive to the stress of exercise. The trained groups were subjected to 
4, 8, and 12 weeks of running training. At 4 weeks, ERK1/2 still displayed significant 
phosphorylation at 30 min of exercise compared to resting values; however, at 12 weeks, 
ERK1/2 was no longer stimulated at 30 min of exercise. Furthermore, the trained heart 
displayed no difference in basal ERK1/2 phosphorylation compared to sedentary 
controls. These data demonstrate that basal ERK1/2 activation is not increased following 
chronic exercise training and that ERK1/2’s sensitivity to exercise may be blunted as a 
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result of training in cardiac muscle. Potentially, the blunted response of ERK1/2 
activation following endurance training observed by Iemitsu et al. could be due to lower 
H2O2 production or decreased sensitivity of ERK1/2 to H2O2. In contrast, a 10-week, 
chronic training study of C57BL/10 mice observed a significant increase in the basal 
phosphorylation of ERK1/2 in the exercised group; however, this study did not control 
for acute training effects since they sacrificed immediately after the last training bout 
(142), which diminishes the ability to associate any observed changes to chronic exercise 
training. The lack of studies displaying exercise-induced alterations in ERK1/2 activity 
validates the need for further investigation.  
 A critical by-product of IR is H2O2, a compound highly implicated in the damage 
associated with IR injury. In fact H2O2 has been shown to cause damage by activating 
NHE1. ERK1/2 is a necessary mediator of H2O2-induced activation of NHE1, because 
ERK1/2 can directly phosphorylate NHE1 (185). The data presented demonstrate how 
IR- and H2O2-induced activation of ERK1/2 regulates NHE1 activity; however, the 
exercise-induced alteration of ERK1/2 and its potential compensatory changes on NHE1 
activity have not been investigated. In fact, both ERK1/2 and NHE1 have been neglected 
from the entire exercise-induced cardioprotection field. Though many mechanisms have 
been examined, understanding how ERK1/2 and NHE1 fit into the picture will help to 
fully explain the exercise-induced cardioprotection framework. 
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Mechanisms of exercise-induced cardioprotection. 
 The protective effect of exercise on the heart has been studied for decades. Sound 
evidence has displayed that pathological hypertrophy, impaired glucose metabolism, and 
IR injury (21,22) are all attenuated by exercise training. With focus given to IR injury, 
the mechanisms by which exercise confers this protection are not completely clear; 
however, some have provided more compelling evidence than others (as noted in Figure 
1). Mechanisms such as antioxidants and heat shock proteins have received a great deal 
of attention, while other probable mechanisms such as NHE1 have been unexplored. 
Recent findings help show that most of the protection may be directly afforded by non-
mitochondrial mechanisms; however, the mitochondrion is a central focus of the damage 
created by IR injury due to its role in mediating cell death. Regardless of definitive 
protective mechanisms, the exercise trained cardiac phenotype presents with improved 
hemodynamics and cell function following an ischemic insult compared to non-trained 
hearts. This review seeks to shed light on where the protection predominates.  
 
Non-mitochondrial mechanisms of exercise-induced cardioprotection. 
 Thirty percent of the heart cell is occupied by mitochondria, which supply the vast 
majority of energy to the cell. When the mitochondria are not supplied with oxygen to 
accept the final electron, the coupling between oxidation of the electron transport chain 
and phosphorylation of ADP is ultimately stopped. The cell switches its energy reliance 
to glycolysis, which supplies much less ATP per glucose molecule, thereby lowering the 
energy state of the cell. Processes like inter-membrane ion homeostasis and sarcoplasmic 
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reticulum (SR) Ca
2+
 uptake use the ATP-dependent proteins Na-K ATPase and 
SERCA2a, respectively. The marked reduction of ATP causes these proteins to fail. 
Decreasing the activity of Na-K ATPase produces an increase in intracellular Na
+
 (Na
+
i) 
and extracellular K
+
. The increase in Na
+
i can lead to increased intracellular Ca
2+
 (Ca
2+
i) 
(as discussed below), while the increase in extracellular K
+
 can lead to decreased cell 
excitability and arrhythmia (68). In fact, IR injury is associated with depressed Na-K 
ATPase activity (180). When that activity is restored using oubain preconditioning, the 
heart is protected from injury (157). Interestingly, the hearts of high capacity runners 
have enhanced Na-K ATPase activity (34). This altered activity could be due to reduced 
regulatory inhibition by phospholemman, a regulatory protein of the Na-K ATPase; the 
phosphorylation of phospholemman removes its inhibitory control on the ATPase, 
meaning an increased constitutive phosphorylated state could be responsible for the 
enhanced Na-K ATPase activity. Five days of swimming training in Wistar rats increased 
the phosphorylation of phospholemman (80), but this exercise effect was not seen in 
humans after 10 days of training (13). 
 SERCA2a is responsible for removing free Ca
2+
i from the cytosol by loading it 
into the SR. The lowered energy state of ischemia decreases the activity of SERCA2a 
leading to a rise in Ca
2+
i. Additionally, SERCA2a content is attenuated in diseased hearts 
(4). The large Ca
2+
i concentration is a product of the decline in activity and content, and 
precedes mitochondrial Ca
2+
 overload – a critical point in the fate of the cell. Again, 
exercise seems to create an adaptation designed for protection, since expression of 
SERCA2a is increased in high exercise capacity rats compared to standard exercise 
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capacity rats (162) and in rats that displayed protection from myocardial infarction 
following exercise training (4). Additionally, exercise prevented the decline in SERCA2a 
content during heart failure progression in dogs (123). SERCA2a is regulated by 
phospholamban, which removes its inhibition upon phosphorylation. SERCA2a activity 
is not altered in rats after 12 weeks of training (54); however, Kemi et al. observed in 
adult female mice that 6 weeks of high-intensity exercise increased the activity of 
SERCA2a, partly due to a decrease in the phospholamban-to-SERCA2a ratio (112). A 
decrease in this ratio could prove beneficial since ischemia induces greater inhibition of 
SERCA2a via dephosphorylation of phospholamban in rats (178). Deductive reasoning 
suggests that exercise-induced protection against IR may be mediated partly by its effect 
on these ATP-dependent proteins; however, these exercise-induced changes have not 
been studied in the ischemic heart, creating an incomplete picture of their relationship 
with exercise. 
 The decreased energy state during ischemia triggers an increase in glycolysis for 
greater ATP production. The increased glycolytic flux coupled with depressed 
mitochondrial function leads to an increase in lactic acid production via lactate 
dehydrogenase. The accumulation of metabolic by-products in addition to the oxygen 
deprivation is what separates the detriment of ischemia from that of anoxia with 
sufficient blood flow (58). The increased H
+
 content reduces the pH of the cell (to levels 
between 5.5 and 6) (183) and is a stimulator of the Na
+
-H
+
 exchanger-1 (NHE1). This 
sarcolemmal protein responds to the change in pH by extruding one H
+
 in exchange for 
one Na
+
 ion, which leads to an accumulation of Na
+
i. NHE1 has been implicated as a 
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point in the calcium-overload cascade, since the increased Na
+
i leads to cytosolic calcium 
accumulation via the Na
+
-Ca
2+
 exchanger (NCX). Specifically, overexpression of NHE1 
is associated with a number of pathologies including diabetes, hypertension, and 
pathological hypertrophy (109), resulting in greater IR-induced damage and eventual cell 
death.   
 NHE1 transcript has been observed to increase following exercise training (214); 
however, recent evidence from our lab shows that NHE1 protein content is decreased 
following treadmill training in adult female Sprague-Dawley rats (67). This decrease 
could prove beneficial by decreasing Na
+
i accumulation during reperfusion. Additionally, 
a decrease in H
+
 extrusion from the cytosol leads to a maintained intracellular acidic pH, 
and the mitochondrial permeability transition pore is inhibited as the cytosolic pH drops 
below 7 (87). Supporting this idea is the cell survival and preserved cardiac function 
following an IR insult in the presence of an NHE1 inhibitor. During and following IR, 
protection from inhibition has been indicated by a decrease in the release of creatine 
kinase (48,147) and lactate dehydrogenase (48,106,147,225) from the cell, improved 
recovery of left ventricular end-diastolic pressure (41,160), reduced infarct size 
(119,134,147,167), greater coronary flow (41,225), and decreased cytosolic and/or 
mitochondrial Ca
2+
 overload (48,106,174,199,207). Additionally, NHE1 inhibition has 
attenuated caspase-3 activation, Na
+
 and Ca
2+
i accumulation, mitochondrial Ca
2+
 overload 
and membrane potential depolarization following an H2O2 insult (195). These noted 
protective effects transcend model type and duration of IR. One human study using the 
NHE1 inhibitor cariporide displayed a decreased incidence of death and non-fatal 
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myocardial infarction; unfortunately, no clinical trial has been able to substantiate the use 
of cariporide due to elevated cerebrovascular events associated with the drug (131). 
Nonetheless, basic models have shown that NHE1 inhibition leads to cardioprotection 
(199,225). This evidence strongly supports why a decreased expression of NHE1 could 
potentially provide protection through similar mechanisms. Future studies need to focus 
on exercise-induced alterations to NHE1 activity, since a few studies have shown that 
NHE1 activity may be more critical to cellular effects than NHE1 content (139). 
 The NCX is normally involved in cellular depolarization as it creates an 
electrogenic potential across the cell membrane by extruding Ca
2+
 from the cytosol; as 
the NCX works in the forward-mode by extruding one Ca
2+
 for three Na
+
, the cell 
progressively becomes more positive. Unfortunately, during IR when Na
+
i concentrations 
rise due to depressed NK ATPase activity and enhanced NHE1 activity, the NCX works 
in reverse-mode to extrude the Na
+
i. The Ca
2+
 brought in by this protein is a major source 
of the Ca
2+
 overload during IR. Inhibition of NCX attenuated diastolic Ca
2+
 overload and 
cardiac dysfunction associated with 8 min of ischemia in rat ventricular myocytes (209). 
The effect of exercise on this protein is unclear, however. In 1989, Tibbits et al. showed 
that 11 weeks of exercise training in adult female Sprague-Dawley rats decreased the Km 
of NCX for Ca
2+
, which was thought to enhance the uptake of Ca
2+
 for the contractile 
elements, providing a mechanism for improved contractile performance during exercise. 
Evidence supported that the role NCX played in Ca
2+
 entry was critical to the enhanced 
stroke volume accompanying exercise (198). In support of the importance of NCX on 
contractile performance, exercise and adenoviral gene transfer increased NCX current 
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(224) and protein content (188), respectively, to rescue the contractile dysfunction 
produced from myocardial infarction. Evidence becomes muddled in the light that two 
other studies demonstrated that chronic training produced a decrease in NCX current 
(150) and no change in either NCX current or protein content (124). A decrease in NCX 
reverse-mode current would decrease Ca
2+
 entry during reperfusion. If exercise produces 
no change in NCX current or content, then exercise-induced alterations upstream (i.e. 
NHE1) could prove to be a vital site of protection. Further research determining the effect 
of exercise-induced changes of NCX (content and activity) in relation to IR is warranted.  
 During non-pathological situations, a major mechanism of Ca
2+
 entry is the 
dihydropyridine receptor (DHPR) located on the plasma membrane. Though, during IR 
this receptor plays no significant mechanism in Ca
2+
 overload (209). Wei et al. 
independently and dually inhibited NCX and DHPR and observed that inhibition of 
DHPR produced no significant difference from control diastolic Ca
2+
 values, while 
inhibition of NCX caused a marked reduction. Furthermore, exercise produced no change 
in DHPR protein content (135), suggesting that DHPR is not a mediator of protection and 
supporting that NCX likely is a more significant mediator of IR-induced damage.  
ATP-sensitive potassium (KATP) channels exist on both the cardiac sarcolemmal 
and mitochondrial membranes, and are responsible for matching membrane excitability 
with the cellular energy status. These heteromultimers have two types of subunits – 
inward rectifiers, KIR6.2, and sulofnuryl receptors, SUR2A; a 1:1 stoichiometry between 
the two subunits is sufficient for channel formation and assembly. The SUR2A subunit 
responds to the cellular ATP/ADP ratio by affecting the opening or closing of the KIR6.2 
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subunit (3). The inhibition ATP imposes on the channel is offset by the presence of ADP, 
supporting why the nucleotide ratio provides better control than either compound 
independently (62). When ATP/ADP falls during ischemia and the channel opens, the 
cell is hyperpolarized by shifting the membrane potential toward that of the K
+
 
equilibrium potential (3). Channel opening shortens the cardiac action potential, limiting 
Na
+
 and Ca
2+
 entry into the cell, thereby reducing energy requirements for ionic 
homeostasis (69). In addition, reducing Ca
2+
 uptake is a well-known solution for 
decreasing IR-related injury (22). 
The sarcolemmal ATP-sensitive potassium channel (sarcoKATP) presently is one 
of the mechanisms of major focus in the exercise-induced cardioprotection literature, and 
evidence has supported its role in providing protection. A KIR6.2 knockout proved that 
this channel is necessary to acquire the benefits of training, since knockout mice 
displayed impaired cardiac contractile function during and following the exercise 
protocol (107). Additionally, recent work by Zingman et al. showed that the exercise-
induced increase in sarcoKATP content enhanced the rate and magnitude of action 
potential shortening during increasing intensities, which significantly reduced cardiocyte 
energy consumption (227). Chronic exercise training has been shown to increase the 
protein content of both KIR6.2 and SUR2A subunits following both short- and long-term 
training (27,29). The increased content of these subunits was highly correlated to 
decreased infarct size following 1 hr ischemia and 2 hr reperfusion, and this protection 
was abolished following pre-treatment with the sarcoKATP inhibitor HMR1098 (a 
cardioselective KATP channel blocker that works on both KIR6.2 and Sur2a) (27,29,37). 
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Furthermore, pharmacological opening of the sarcoKATP displayed cardioprotection 
during an IR insult (85). Opposing the protective effect of the sarcoKATP is a study by 
Quindry et al. (166) that showed HMR1098 did not reduce the anti-arrhythmic protection 
conferred by short-term exercise. Interestingly, Quindry et al. provided HMR1098 at a 
time point outside that which has been shown protective and in a manner inconsistent 
with that which was referenced (79). Both Brown (27) and Quindry (166) used short-term 
exercise training at comparable intensities; however, a major difference was between the 
IR protocols – 60/120 min to 20/30 min – suggesting a time-dependent protection 
provided by the channel. For example, one channel may better protect the cell from 
arrhythmia whereas the other better protects from death. The disparity between results 
and IR model support the need for further investigation.  
 Heat shock proteins (HSP) provide transport, compartmentalization, and proper 
folding stability to proteins within the cell and assist in cell signaling (145). These 
proteins were named due to their upregulated expression in response to temperature 
increases, and they are classified based on their molecular weight. For instance, HSP70 
refers to the family of HSPs with a molecular weight in the 70 kDa range. HSPs range 
from small (i.e. aB-crystallin, HSP10, HSP25, HSP27) to large (i.e. HSP60, HSP72, 
HSP90, HSP110) proteins, and are dispersed throughout the nucleus, cytosol, and 
mitochondria; specifically, HSP75, 60, and 10 have been observed in the mitochondria. 
The upregulation of these proteins in response to stress and their protection against IR 
injury has been noted for many years (194,218).  
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 Possible mediators of the HSP response to exercise are stretch of stretch-activated 
channels, ATP depletion, oxidative stress, and hyperthermia (145). Activation of stretch-
activated channels increases activation of heat shock factor-1 (HSF1), the transcription 
factor involved in hsp transcription and necessary for upregulating HSP protein content. 
(33). The increased myocardial stretch associated with exercise makes this a relevant 
mediator. Moderate decreases in ATP during ischemia correlate with HSF1-DNA 
binding, suggesting a critical ATP level is needed for HSF1 activation (32). However, in 
the non-ischemic exercising myocardium, ATP/ADP levels do not markedly change since 
the heart is truly never at rest (11), thus diminishing this mechanism as a mediator for the 
HSP response from exercise. Oxidative stress increases HSF1-DNA binding (145). For 
instance, GSH depletion, a product of ischemia, produces a marked increase in the 
oxidized state of the cell and, independent from exercise, causes an increase in HSF1-
DNA binding (151). However, the heart does not produce significant increases in ROS 
during exercise (201), minimizing the role of oxidative stress as a mediator to the 
exercise-induced HSP increase. Both heat shock and exercise increased HSF1-DNA 
binding in male and female adult rats were compared to control, but this study did not 
tease apart heat stress from the exercise stress.  
 Many authors have discovered that exercise produces a stress that elicits changes 
in multiple HSPs. Specific to mitochondria, changes to HSP60 and HSP10 are unclear. 
Studies have shown that exercise training causes a decrease, increase or no change in 
mitochondrial HSPs (8,89,128,165). The most concrete evidence for a change in a HSP 
favors cytosolic HSP72 – the inducible form of HSP70. Exercise increases HSP72 after 
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short- and long-term training at moderate-to-high intensity (89,90,192) and long-term, 
moderate intensity (128); the threshold intensity for HSP70 upregulation in the adult rat 
heart appears to be at or above 24 m/min (133). This increase in HSP72 is a result of the 
increased core temperature associated with exercise but is not required for exercise-
induced protection. Our lab was the first to show that when rats’ core temperatures were 
not allowed to increase by exercising them with wet fur in a cold room, HSP72 was not 
elevated, yet improved recovery following IR was still observed (192,193). Cold running 
produced no upregulation of HSP72, yet pump function following IR was still 
significantly enhanced compared to controls (90,192). This finding was confirmed by 
studies from Powers’ lab (89). The fact that heat shock produced similar protection and 
an increase in HSP72, supports that exercise mediates protection through other 
cardioprotective factors and is not dependent upon HSP72 (192). HSP72 is not 
discounted as a protective adaptation resulting from endurance training due to its many 
beneficial effects in the cell and integration with other mechanisms (55), but the present 
findings gives support to other adaptations within the heart being key to its protection by 
exercise. 
 Proteases are enzymes involved in cleavage and degradation of proteins. Calpains 
are Ca
2+
 activated proteases implicated in the degradation of cytosolic Ca
2+
 regulating 
proteins (78) and mitochondrial proteins necessary for cell function (36). IR significantly 
increases calpain activity and impairs cardiac work in sedentary control rats, and exercise 
training attenuates this response in a manner comparable to calpain inhibition. The work 
by French et al. (77,78) indicates that this is not due to an exercise-induced decrease in 
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calpain or an increase in calpastatin, an endogenous inhibitor of calpain (78). Instead, 
they concluded that the attenuated increase in calpain activity following IR in the 
exercise trained heart was mediated indirectly through increased MnSOD, suggesting 
oxidative stress may enhance calpain activation. In support of this, the antioxidant trolox 
abolished the activation of calpain (211). Furthermore, taurine administration inhibited 
NADPH oxidase-induced calpain activation (122). Although an elevation of MnSOD 
could attenuate calpain-assisted Ca
2+ 
overload by decreasing calpain activation, there are 
other adaptations that directly decrease Ca
2+ 
overload and several studies have reported 
that MnSOD was not elevated in the heart by exercise training.  
 The iNOS-COX-2 combination has proved to be a major mechanism by which 
ischemic preconditioning protects the heart (18,191). iNOS is upstream of COX-2 and 
produces nitric oxide (NO), which can protect the myocardium possibly by inhibiting 
Ca
2+
 influx, decreasing myocardial oxygen demands, and opening the mitochondrial KATP 
channel. NO also activates COX-2, which provides protection via its prostanoid products, 
PGI2 and PGE2. The combined effect of iNOS and COX-2 results in ischemic 
preconditioning of the heart (51). Although chronic exercise training increases COX-2 
mRNA levels (128), exercise does not increase COX-2 protein content or activity in 
young or aged hearts (164). Additionally, iNOS does not appear to play a significant role 
in exercise-induced preconditioning against IR injury in rats since this enzyme is not 
elevated in the heart by chronic exercise programs (47,95), and inhibition of iNOS by L-
NAME did not alter the improved recovery following IR (193). 
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 Though research is not completely conclusive, exercise produces alterations to 
non-mitochondrial mechanisms that appear to create an environment more resistant to the 
stress of IR. The increased NK-ATPase activity, increased SERCA2a expression, 
decreased NHE1 content, neutral in NCX, increased sarcoKATP, and increased HSPs 
comprise a list of exercise-induced adaptations theoretically designed to protect the cell 
from the very detrimental IR-induced Ca
2+
 overload  and protein misfolding and 
aggregation. Not all of these mechanisms have been examined against IR, but some have 
been observed to provide protection against IR injury.  
 
Mitochondrial mechanisms of exercise-induced cardioprotection.  
 Mitochondria produce the greatest source of reactive oxygen species in the body 
(121). Estimates of 2-5% of the oxygen used during normal mitochondrial respiration 
have been reported to contribute to the formation of ROS, such as O2
-
 and H2O2 (20). 
Although 2-5% may be an overestimation, the production of free radicals during ATP 
production cannot be argued (25). In skeletal muscle, an increase in oxygen consumption 
due to exercise causes an increase in ROS production (10), which has been indirectly 
supported by increased lipid peroxidation (52) and exhaled pentane levels during exercise 
(59). In the heart, however, Traverse et al. collected blood samples from the region of 
heart supplied by the left anterior descending artery and used electron paramagnetic 
resonance to show ROS production was not increased during exercise compared to rest 
(201). This suggests that the basal level of release of ROS is lower in the heart compared 
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to the skeletal muscle and/or the heart is more effective than skeletal muscle at 
controlling ROS accumulation during exercise using endogenous antioxidants.  
 Evidence exists for exercise-induced changes in the electron transport chain that 
result in less mitochondrial ROS production (103,189). Male 24-month old Fischer 344 
rats displayed decreased H2O2 production in both the IMF and SS mitochondrial 
subfractions following lifelong voluntary wheel running, though this change could have 
been age related since no young rats were included (103). Marcil et al. used young female 
Sprague-Dawley rats but observed no change in ROS production in trained mitochondria 
compared to their sedentary counterparts, suggesting this specific adaptation may be 
strain, gender, and/or age dependent (127). Our lab used young male Fischer 344 rats to 
determine if exercise trained cardiac mitochondria produced lower H2O2 levels in 
response to a Ca
2+
 load compared to sedentary mitochondria (189). The trained isolated 
mitochondria, energized by succinate at Complex II, produced less H2O2 in the presence 
and absence of a Ca
2+
 load compared to sedentary mitochondria. Interestingly, the 
difference in H2O2 production between the trained and sedentary was abolished upon the 
addition of the Complex I inhibitor rotenone, suggesting that an adaptation at Complex I 
is responsible for the decreased H2O2 production. Additionally, this evidence supports 
that this adaptation may be gender and/or strain dependent. During reperfusion, an 
overload of mitochondrial Ca
2+
 can inhibit Complex I activity, which may possibly 
negate this adaptation from the cardioprotective equation. Understanding whether the 
mitochondrion adapts by reducing free radical generation at other complexes, especially 
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those downstream of the ubisemiquinone radical, would add support to whether the 
exercise phenotype is truly a result of the mitochondrion.   
 Evidence also exists that, compared to skeletal muscle, the heart has a more 
effective antioxidant system. Mitochondrial antioxidants MnSOD and glutathione 
peroxidase (GPx) play a role in protecting the mitochondria and the cell from oxidative 
stress, but their role in exercise-induced cardioprotection remains unclear. MnSOD is a 
predominant antioxidant in the mitochondria. An increase in MnSOD observed with 
exercise training is associated with reduced infarct size, percent of apoptotic cells, and 
oxidation of Ca
2+
 handling proteins following an ischemic insult (77). However, even 
with no change in any major antioxidant enzyme after exercise, protection following IR is 
still observed in the rat heart (29,191,193). The studies by Taylor et al. (193) and French 
et al. (77) both ran young adult male rats at an intensity ~70% VO2max and used similar 
IR times; however, Taylor et al. ran Fischer 344 rats for 2 days while French et al. ran 
Sprague-Dawley rats for 5 days, suggesting MnSOD upregulation is strain dependent 
and/or time sensitive. Interestingly, Brown et al. (29) ran young adult male Sprague-
Dawley rats for 5 days at ~70% VO2max – the same as French et al. (77) – and saw an 
exercise-mediated decrease in infarct size without a change in MnSOD protein content. 
Unfortunately, the comparison is not completely conclusive since enzyme activity and 
protein content were being separately evaluated. 
 MnSOD is upregulated in response to oxidative stress or an increase in ROS (61). 
If ROS are not appreciably increased during exercise, then what is the stimulus for an 
increase in MnSOD upregulation? Studies where rats were run in the cold show no 
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evidence of changes in MnSOD, suggesting that temperature may be causal. The studies 
discussed above used short-term training, but even long-term training has not consistently 
upregulated MnSOD; exercise protocols longer than 9 weeks produce no observable 
changes to the enzyme (90,120,138). Most chronic training protocols use a constant 
intensity that becomes relatively easier over time, attenuating the stimulus over the 
training period and possibly diminishing the stimulus for MnSOD upregulation. A 10-
week treadmill protocol that maintained relative intensity at 75%  VO2max displayed a 
continual increase in MnSOD (158). However, the same exercise protocol produced no 
change in MnSOD when performed by Demirel and colleagues (56). An inconsistency 
between the sensitivity of the measures used to detect MnSOD changes could be a reason 
for this conflict. A discrepancy of MnSOD changes exists at all possible levels of 
exercise stimuli, weakening the argument for this enzyme as a critical axis of exercise-
induced cardioprotection. French et al. (77) even conceded that MnSOD alone could not 
be the only mediator of protection since loss of MnSOD via antisense oligonucleotides 
did not completely abolish the exercise-induced protection. This argument opens the door 
for other antioxidants. 
 Glutathione peroxidase converts H2O2 to H2O using reduced glutathione (GSH). 
Depletion of GSH levels is highly implicated in the contractile dysfunction and 
arrhythmogenesis associated with IR. Maintaining GSH levels and GPx activity during 
IR can attenuate damage. Transgenic overexpression of GPx in the mitochondria of mice 
improved developed pressure and peak systolic pressure following 20 min of global no-
flow ischemia (49). The glutathione oxidant diamide decreases the GSH-to-GSSG ratio 
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by both increasing GSSG (oxidized glutathione) and decreasing GSH levels. Application 
of diamide to isolated cardiocytes induced ventricular tachycardia and ventricular 
fibrillation (26). Moreover, diamide experiments displayed that even a 30% reduction in 
GSH-to-GSSG can trigger mitochondrial membrane potential oscillation (182). These 
data elegantly display the critical nature of maintaining antioxidant reducing potential. 
Unfortunately, exercise research markedly shows that GPx levels are not altered due to 
exercise training from short-term to lifelong wheel running (22,56,57,90,103,164,189). 
One study saw an increase in GSH levels between an exercise group and sham group, but 
the difference was negated after a bout of IR significantly reduced glutathione levels in 
both groups (57). In contrast, another study observed no difference in baseline GSH-to-
GSSG levels between exercised and sedentary rats, but these levels were better preserved 
in exercise groups receiving both diamide and IR (76). The majority of evidence further 
attenuates the support for a mitochondrial antioxidant-mediated role for exercise-induced 
protection.  
 The fact that exercise training reduces the oxidative stress presented to the cell in 
normal situations and during IR is well established. What is not currently known is how 
the cell, specifically the mitochondria, reduces this stress. The study by our lab (189), 
displaying a decrease in mitochondrial H2O2 production, measured an exercise-induced 
increase in catalase activity, an antioxidant of H2O2. Had antioxidants played a role in the 
decline of H2O2 production, then a decrease would have been apparent without the 
Complex I inhibitor rotenone, thus providing evidence that the exercise-induced decrease 
in H2O2 is not purely a result of antioxidants. Judge et al. (103) observed that lifelong 
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wheel running reduced mitochondrial H2O2 production and that MnSOD decreased in 
runners, which reflects and further supports that mitochondria reduce free radical 
generation. Finally, a decrease in lipid peroxidation following IR was observed in female 
Sprague-Dawley rats after 10 weeks of running, and this was accompanied by no change 
in either GPx or MnSOD activities. The compiled evidence supports that a decrease in 
ROS production by the exercised mitochondria may play a greater role in reducing the 
oxidative stress presented to the cell rather than an increase in mitochondrial 
antioxidants. 
  ROS production can loop back to cytosolic Ca
2+
 pools, thereby affecting 
intracellular Ca
2+
 levels. For example, RyR thiol groups can be oxidized resulting in 
altered Ca
2+
 release and increased cytosolic Ca
2+
 concentrations (12,66,116). Cytosolic 
Ca
2+
 enters the mitochondria via the Ca
2+
 uniporter (mCU) by the electrochemical 
gradient of ~-180mV across the inner mitochondrial membrane (175). As the positively 
charged Ca
2+
 enters the matrix, the polarity between the cytosol and mitochondria is 
dissipated, which then decreases Ca
2+
 influx. In a physiological setting where 
mitochondria partly buffer cytosolic Ca
2+
 transients, this depolarization is offset by 
normal respiration and transfer of H
+
 to the intermembrane space (146). During ischemia, 
however, decreased oxygen levels reduce electron flow and H+ transfer, allowing 
unopposed influx of Ca
2+
 into the mitochondrial matrix. Upon reperfusion and 
subsequent electron flow, the potential is re-established allowing for greater increases in 
mitochondrial Ca
2+
 (202). This mitochondrial Ca
2+
 overload can lead to MPTP opening 
(155).  
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 A mitochondrion more tolerant to these increases in Ca
2+
 would better protect the 
cell from MPTP opening. The Ca
2+
 uniporter is the major mechanism by which Ca
2+
 
enters the matrix during normal oscillations (146). Ischemic preconditioning results in 
decreased mitochondrial Ca
2+
 content following IR by attenuating Ca
2+
 influx through the 
Ca
2+
 uniporter (223). However, little research has observed the effect of exercise on this 
channel. Only indirect evidence is available from Marcil et al. (127), who saw that 
trained mitochondria did not have different Ca
2+
 uptake kinetics compared to their 
sedentary counterparts, suggesting that mitochondria are not protected from Ca
2+
 influx 
via this mechanism. In fact, mitochondria may not be better protected or more resilient to 
given Ca
2+
 loads as a result of exercise training. Our lab (189) demonstrated that MPTP 
opening (measured by decreases in light scattering) was similar between trained and 
sedentary mitochondria in response to a given Ca
2+
 load. Furthermore, the Ca
2+
 retention 
capacity of mitochondria from exercised animals was significantly lower than that of 
sedentary animals following 10 days of exercise training (75). Conversely, Marcil et al. 
(127) showed that trained mitochondria displayed an increased tolerance to Ca
2+
-induced 
MPTP opening using both light scattering and Calcium Green 5N. Whether or not 
mitochondria are more tolerant to Ca
2+
-induced MPTP opening is still somewhat under 
question. Based on the studies mentioned, a gender difference could be speculated as 
cause for mitochondrial Ca
2+
 tolerance. However, would the mitochondria need to be 
more tolerant to Ca
2+
 if the cell took-up less cytosolic Ca
2+
 during an IR insult? The 
evidence so far suggests that mitochondria may indirectly protect themselves from extra-
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mitochondrial stresses by producing fewer free radicals, which would assist in reducing 
Ca
2+
i levels. 
The mitochondrial KATP (mitoKATP) has been speculated to provide protection to 
the mitochondria against Ca
2+
 overload during IR. Opening of the mitoKATP provides 
protection by partial depolarization of the mitochondrial membrane potential; this results 
in a decrease in mitochondrial Ca
2+
 influx and attenuates Ca
2+
 overload. Whether 
mitoKATP opening mediates exercise-induced cardioprotection is still of debate. Quindry 
et al. (164) inhibited the mitoKATP before 20 min of ischemia and observed that the 
protection against arrhythmia was abolished. Brown et al. (27), however, inhibited the 
mitoKATP before 60 min of ischemia but did not see an abolition of exercise’s protection 
against infarct sparing. Again, there may be a IR time threshold for mitoKATP protection 
as discussed with sarcoKATP. This picture becomes more muddled since dogs that 
exercised immediately or 24-hours before coronary occlusion exhibited a significant 
decrease in infarct size following 60 min of ischemia, and mitoKATP inhibition 
abolished this protection (60,152). Additionally, the requirement and ability of mitoKATP 
to protect the heart from aortic constriction and H2O2 stimulation has been displayed 
(141,217), which lends support to the significant role of both KATP channels and the need 
for further research.  
To date, the evidence remains unclear as to whether mitochondria are directly 
morphologically altered to protect themselves from Ca
2+
-induced MPTP opening or are 
indirectly protected via decreased ROS production. Ciminelli et al. (38) used the 2-deoxy 
[
3
H]glucose ([
3
H]DOG) entrapment method to determine if exercise training protected 
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the mitochondria from MPTP opening. These authors observed that short-term exercise 
(5 days at ~75%VO2max) significantly decreased pore opening in response to 30 min of 
ischemia and 40 min of reperfusion. However, this study failed to uncover any 
mechanisms of protection (38). Possible mechanisms include those already mentioned 
(i.e. ROS, AOX, and mitochondrial membrane channels); however, extramitochondrial 
proteins involved in regulation of MPTP opening or downstream effectors of the death 
signal present interesting options as well.  
 Bcl-2 and Bax proteins assist in controlling pore opening and regulating 
mitochondrial dysfunction. Activation of the anti-apoptotic factor Bcl-2 has been shown 
to increase the Ca
2+
 threshold necessary for MPTP opening (226), and to inhibit ATP 
hydrolysis by F1-F0 ATPase during ischemia (99). On the other hand, activation of the 
pro-apoptotic factor Bax causes its translocation from the cytosol to the mitochondria, 
where it inserts into the mitochondrial membranes and forms a protein-permeable pore 
(117). Bcl-2 prevents pore permeabilization by inhibiting Bax (86). Thus, decreases in 
the pro-apoptotic and increases in the anti-apoptotic proteins of the cell attenuate 
mitochondrial dysfunction and cell death. Evidence exists that exercise increases the Bcl-
2-to-Bax ratio (53,156,181); a decrease in this ratio is highly correlated to an increase in 
the apoptotic threshold (53). Moderately intense treadmill exercise of at least 8 weeks 
decreased the Bcl-2-to-Bax ratio by either increasing Bcl-2 levels or decreasing Bax 
content (53,156,181). The only group not to see a difference in the ratio was Kwak et al. 
(118) but they used Fischer 344 rats, which was a different strain than the other studies 
that saw a significant change and suggests a possible strain difference. The Bcl-2 and 
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Ca
2+
 threshold relationship observed by Zhu et al. (226) could allow one to speculate that 
the exercise-induced increase in the Bcl-2-to-Bax ratio is a potential mediator of 
protection from mitochondrial Ca
2+
 overload; however, experiments discerning this 
relationship have not been performed. 
 Following MPTP opening, there is a release of pro-apoptotic factors from inside 
the matrix, which initializes a deleterious cascade. The most well-known scenario is the 
release of cytochrome c and the eventual activation of caspase-3. Exercise does not seem 
to alter the factors AIF, caspase-3 or caspase-9 following at least 8 weeks of moderately-
intense treadmill exercise (53,156,181); however, this lack of effect does not seem 
critical since inhibition of the caspases does not prevent cell death. Cell death is only 
delayed because upstream mitochondrial membrane potential loss is not inhibited (23). 
This evidence further emphasizes the importance of the pore regulators, the Bcl-2 family 
of proteins, which are implicated in alterations of the mitochondrial membrane potential. 
It also further emphasizes the importance of mechanisms involved in preventing Ca
2+
i 
overload. Additionally, studies observing whether trained isolated mitochondria have an 
increased Ca
2+
-induced pore opening threshold would serve well from determining 
altered levels Bak, a pro-apoptotic protein that is already present in the mitochondria as a 
membrane protein and does not have to be translocated from the cytosol like Bax (117). 
To our knowledge, exercise studies have only observed changes to Bcl-2 and Bax; further 
research should include other Bcl-2 family proteins.  
 Regardless of whether a change in the apoptotic threshold exists as a result of 
training, exercise still affords protection to the cardiocyte following an ischemic insult. 
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This would suggest that exercise may be affecting the activity of proteases involved in 
the apoptotic cascade. The protection has been observed in the form of decreased MPTP 
opening (38), cytochrome c release (111), caspase-3 activity (77,163,222), CK and LDH 
release (222), percent apoptotic cells (77,163,165,222), and infarct size (77,165,222). The 
protection observed biochemically is translated functionally as improved systolic (222) 
and diastolic function (22,28,222), cardiac output (21,22), coronary flow (22,28), and 
cardiac work (22) following an ischemic insult. Zhang et al. (222) swam adult male 
Sprague-Dawley rats for 8 weeks to induce cardiac hypertrophy. After hearts were 
subjected to 30 min of ischemia, trained hearts demonstrated reduced caspase-3 activity, 
and a decrease in percent of apoptotic cells and infarct size. Trained hearts also 
developed improved systolic and diastolic function post-reperfusion. To delineate a 
potential cellular mechanism involved in this cardioprotection, the PI3K inhibitor 
wortmannin was added to the hearts 15 min pre-reperfusion; the addition of wortmannin 
abolished protection, suggesting that protection is partly afforded by PI3K-Akt 
mechanism. More work is needed to uncover the signaling pathways responsible for the 
anti-apoptotic protection that exercise confers. In fact, none of the MAPKs have been 
examined in relation to exercise and IR injury. Examining the signaling pathways that 
regulate some of the cardioprotective proteins will unravel new questions about how 
exercise confers protection to the heart.  
 Protecting mitochondria from damage is critical to protecting the cell from 
damage and death. Some of the mitochondrial mechanisms contributing to the exercise-
induced cardioprotective phenotype include increased antioxidants, decreased ROS 
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formation, increased mitoKATP content, and increased Bcl-2-to-Bax ratio. An increase in 
antioxidants may possibly be a key component of this exercise phenotype, but MnSOD 
data has not been consistent and the majority of studies report glutathione does not 
change in response to training. Evidence surrounding mitoKATP has not been conclusive; 
the use of a more consistent model may help. Data suggests that the increased Bcl-2-to-
Bax ratio observed in the trained animal could be a contributor to protection, but more 
work in relation to IR injury is needed. We believe the main adaptation contributing to 
mitochondria’s self-protection is the reduction in ROS production, specifically through 
alterations made to complex I. The decreased ROS alleviates one contribution to Ca
2+
 
overload, since oxidation of key Ca
2+
-regulating proteins is reduced. Because exercised 
mitochondria are not more tolerant to Ca
2+
 loads, we believe not only that an adaptation 
that reduces ROS production may be the most relevant, but also that the non-
mitochondrial exercise-induced adaptations that reduce intracellular Ca
2+
 overload 
predominate in the heart cell’s ability to protect itself from IR.  
 
The relationship between exercise, NHE1, and IR injury. 
Skeletal muscle has been shown to increase its NHE1 content in response to 
exercise in humans (96,105) and rats (104). Eight weeks of high-intensity knee-extensor 
exercise and 4 weeks of sprint training displayed increases of 116 (105) and 30% (96) in 
NHE1, respectively. Cells respond to a chronic acid load by increasing NHE1 mRNA 
(205). The high-intensity training results in large amounts of H
+
 production secondary to 
lactic acid formation, thereby stimulating NHE1 production. This result is expected from 
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fiber types more glycolytic than type 1; although, type 1 fibers showed increased NHE1 
expression as well. Skeletal muscle blood flow lags in response to the need of oxygen 
requirement at the start of high-intensity exercise, as metabolites and H
+
 leak into the 
blood to cause dilation of terminal arterioles. This lag time transiently forces even 
oxidative fibers to produce H
+
 by way of anaerobic glycolysis, thereby plausibly 
stimulating an increase in NHE1. On the other hand, the heart’s response to an increase in 
stimulation is flow-mediated, meaning oxygen is delivered to heart cells through the 
coronary circulation in a parallel fashion to that of cardiac output. Cardiac myocytes, 
therefore, do not produce an intracellular environment as acidic as skeletal muscle in 
response to increased stimulation. This concept supports the fact that the cardiac NHE1 
does not have to be upregulated in response to exercise in cardiocytes.  
The only study to examine the effects of exercise on cardiac NHE1 observed 
increases in NHE1 mRNA levels. The training, which was intense enough to induce 
physiological hypertrophy, increased mRNA 130% acutely and 20% at 2 weeks; weeks 4 
and 13 saw trends of upregulation but they were not significant (214), suggesting NHE1 
message may decline back to sedentary levels with more chronic training. Nonetheless, 
these mRNA changes may not have translated into functioning protein due to post-
transcriptional modification. This study did not address the relationship of these 
alterations with IR. 
 One of the most detrimental factors of IR is the production of Ca
2+
i overload. 
Literature has consistently displayed that NHE1 inhibition is protective to the cell, mainly 
due to a reduction in Ca
2+
i overload. Conversely, diseased hearts typically present with 
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increased NHE1 content and activity and elevated Ca
2+
i concentrations. We have shown 
that exercise training decreases NHE1 content by 38%; however, still unknown is 
whether this change confers protection from IR injury, and whether exercise causes a 
change in NHE1 activity. The fact that NHE1 activity may be more important to the 
damage presented to the cell supports why investigating the effect of exercise on NHE1 
activity is necessary (140). Additionally, because non-mitochondrial adaptations from 
exercise seem to be most critical to protection, understanding how exercise affects the 
response of NHE1 to IR will help to clarify and strengthen the framework of the exercise-
induced cardioprotection picture. We believe that NHE1 could be a critical axis of the 
exercise-induced cardioprotective phenotype.  
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Figure 2.1. Exercise-induced cardioprotective mechanisms. 
 
Figure 2.1. Exercise-induced cardioprotective mechanisms. The supported (dark boxes) and 
unsupported (normal boxes) mechanisms of exercise-induced cardioprotection. The unexplored 
NHE1 mechanism is unfolded to display its possible pathways. The bold arrows represent the 
pathways considered in this project, while the boxes represent the features of those pathways 
under review.  
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Abstract. 
 
The effect of exercise training on myocardial NHE1 protein expression was 
examined. Adult female Sprague-Dawley rats were randomly divided into sedentary (S, 
n=8) and exercised (E, n=8) groups. Twenty-four hours after the last exercise bout, hearts 
were weighed and connected to an isolated perfused working heart apparatus for 
evaluation of cardiac functional performance. Heart weight and heart weight/body weight 
from E rats was significantly increased by 7.1 and 7.2% (P < 0.05), respectively, 
compared to S hearts. The E hearts displayed 15% greater cardiac output and 35% 
external cardiac work compared to the S group at both low and high workloads (P < 0.05 
for both parameters). Ventricular tissue from the same hearts was homogenized and 
NHE1 and Na
+
/Ca
2+
 exchanger (NCX) content determined by Western blotting. E hearts 
had a 38% (P < 0.001) reduction in NHE1 content related to S hearts; however, there was 
no difference in NCX content between groups. Cytochrome c oxidase activity in plantaris 
from E group increased by 100% (P < 0.05), and was assessed as a marker of 
mitochondria content and to verify training status. Our data indicate that exercise training 
at an intensity that results in cardiac hypertrophy and improved performance is 
accompanied by decreased NHE1 content in heart.   
 
Key words: Sodium calcium exchanger; Isolated perfused heart; Cardioprotection; Anti-
remodeling; Physiological cardiac hypertrophy 
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Introduction. 
The Na
+
/H
+
 exchanger-1 (NHE1) is a cardiac and skeletal muscle sarcolemmal 
protein that plays a key role in the regulation of cell pH by extruding one intracellular H
+
 
in exchange for one extracellular Na
+
. Upregulation of NHE1 has been extensively 
studied as a central component to the generation of cardiac hypertrophy (for review see 
(39)). Cardiac growth or hypertrophy can be generally classified as either pathological or 
physiological. Pathological hypertrophy includes growth in a diseased state (i.e. 
hypertension and aortic stenosis) and is associated with cell death, reduced cardiac 
function, and heart failure (43). On the other hand, physiological hypertrophy includes 
growth of the heart during postnatal development and in response to chronic exercise 
training and is associated with normal or improved cardiac function (65). In the 
pathological setting, NHE1 activity is increased by increased expression and 
phosphorylation initiated by such stimulants as Angiotensin-II, aldosterone, Endothelin-
1, and reactive oxygen species (ROS) (39). NHE1 activation subsequently results in Na
+
-
dependent Ca
2+
 overload via the sarcolemmal Na
+
/Ca
2+
 exchanger (NCX) (92). The 
increased intracellular Ca
2+
 is thought to then initiate hypertrophy through activation of 
the Ca
2+
/calmodulin-dependent protein kinase II-histone deacetylase pathway (143) or 
calcineurin/nuclear factor of activated T cell transcription factors (212).  Increased NHE1 
also makes the heart more vulnerable to a variety of stresses including ischemia-
reperfusion (IR) injury. The decrease in cytosolic pH that occurs during an ischemic 
event increases NHE1 activity leading to intracellular Na
+
 accumulation. In response, 
NCX works in reverse mode causing Ca
2+
 overload and ensuing contractile dysfunction 
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and cell death. Several studies have shown that NHE1 genetic elimination or inhibition of 
NHE1 activity is protective to the myocardium during IR injury (6,98,101,102,208). 
Overall, an increase in NHE1 in the heart can be considered to be maladaptive. 
Interestingly, the interaction of NHE1 and exercise-induced physiological 
hypertrophy has not been explored. In skeletal muscle this protein aids in attenuating 
exercise-induced cellular acidosis, a contributing factor to muscular fatigue [22].  
Moderate to high-intensity exercise protocols are reported to increase NHE1 level in 
skeletal muscles (96,104,105) thereby enhancing their ability to tolerate an acid load. The 
impact of exercise training on myocardial NHE1 content is uncertain. Intense exercise 
has been reported to acutely increase myocardial NHE1 mRNA expression in rats, but the 
mRNA returns toward sedentary control levels within four weeks as the animals adapt to 
the exercise protocol (214). However, mRNA content does not always correspond to 
expression of its protein and myocardial NHE1 protein content has not been measured in 
response to exercise training.  
Although NHE1 increases in skeletal muscle with exercise and in heart with 
pathological hypertrophy, we hypothesize that it will not increase in the exercise-induced 
hypertrophied heart because the heart is not expected to experience an acid load during 
exercise and because exercise training is reported to decrease ROS production 
(103,159,189). Many investigators, including ourselves, have demonstrated that exercise 
participation provides intrinsic cardioprotection against a variety of pathological 
challenges (30,90,159). Although the cardioprotective mechanisms are not completely 
understood, it seems doubtful that exercise-induced adaptations would include those that 
50 
 
are maladaptive such as an elevation of NHE1. If NHE1 does increase in the exercise 
trained heart, then other protective adaptations must occur to counter the potential 
harmful impact of overexpressed NHE1. To test our hypothesis NHE1 protein expression 
was determined in rat hearts after completing an exercise program previously established 
to produced physiological cardiac hypertrophy (90,144). 
Methods. 
Animals and training. Female, 5-6 month old, Sprague-Dawley rats were obtained 
from the breeding colony maintained by the University of Texas Animal Resource 
Center. Animals were kept on a 12:12-h light-dark cycle and fed ad libitum. This 
investigation was approved by the University’s Institutional Animal Care and Use 
Committee and conforms to the Guide for the Care and Use of Laboratory Animals 
published by the National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
This population has at least four advantages relevant to this study: 1) they have reached a 
stable weight, thus exercise capacity will not change due to age; 2) they have much more 
“enthusiasm” for running on the treadmill than do adult male rats, thus assuring that more 
animals will complete the exercise training protocol without physical or psychological 
injury; 3) they are adults, which is consistent with most people presenting with coronary 
artery disease, and; 4) they have been used successfully for this training protocol 
previously (192). Rats were randomly assigned to one of two groups: sedentary (S) or 
exercised on a treadmill for 5 days/wk up a 6° incline for 5 wks (E). The exercise training 
protocol was modified from a previously used protocol that produced significant cardiac 
hypertrophy with enhanced function and a gene expression profile consistent with 
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physiological hypertrophy (144).  Briefly, rats were habituated to treadmill running for 1 
week. During this week animals ran on a 6° grade gradually increasing the time and 
speed so that at the end of the week they were running for 30 minutes at 25 m/min. 
Following habituation animals began running in the cold (8˚C) at 25 m/min with a fan 
blowing on them to minimize the normal exercise-induced increase in core temperature 
(144). The time was gradually prolonged so that the animals were running for 1 hour per 
day by the end of the first week. Speed was gradually increased until reaching 30m/min 
and then maintained at that speed for the final week of exercise. All exercised animals 
were housed at 23˚C when not running.  
Isolated heart perfusions. Myocardial performance was evaluated 24 hours after 
the last treatment using an isolated, working heart preparation as previously described 
(144). Briefly, rats were anesthetized with an intraperitoneal injection of 40 mg/kg 
pentobarbital sodium and hearts were excised, weighed, and mounted on the perfusion 
apparatus. The perfusate was a modified Krebs-Henseleit buffer containing (in mM): 10 
glucose, 3.0 CaCl2, 118.5 NaCl, 4.7 KCl, 1.2 MgSO4, 24.7 NaHCO3, 0.5 EDTA, and 12 
IU/l insulin. It was gassed with 95% O2-5% CO2 and maintained at 37C. Myocardial 
function was evaluated while working against a low afterload set by an 80 cm high aortic 
column (internal diameter 3.18 mm) and against a high afterload created by inserting a 
1.5 inch 23-gauge needle into the aortic column. Atrial filling pressure was maintained at 
12.5 mmHg throughout. Hearts were electrically paced at 300 beats/min with an electrode 
placed at or near the SA node except for four hearts in S and three hearts in E because 
their intrinsic rate was at or above the target rate. This procedure maintained heart rates 
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within a tight range and avoided problems associated with trying to forcefully slow a 
heart beating at slightly faster than 300 beats/min. The resulting heart rates for the groups 
were (in beats/min): 313.5 ± 7.1 for S and 308.3 ± 4.5 for E during the low afterload, and 
315.5 ± 6.5 for S and 306.9 ± 3.4 for E during the high afterload. Coronary flow (CF) and 
aortic flow (AF) were determined by weighing timed collection of the effluent from the 
pulmonary artery and aortic column overflow, respectively. Cardiac output (CO) was 
determined as the sum of CF and AF, and cardiac external work (COxSP) was defined as 
the product of CO and peak systolic pressure (SP). Oxygen content in the coronary 
effluent was continuously monitored with an in-line oxygen electrode for the 
determination of myocardial oxygen consumption (VO2).  Myocardial efficiency (EFF) 
was calculated by dividing external work by VO2. Hearts were allowed to function at the 
low workload for approximately 25 minutes to assure stability and then switched to the 
high workload challenge for an additional 5 minutes. The beating hearts were then freeze-
clamped and stored at -80C until analysis.  
 Western Immunoblotting: Myocardial left ventricular samples were homogenized 
in 50 mM KH2PO4, 0.1 mM EDTA, pH 7.4 with a Protease Inhibitor Cocktail (Sigma # 
P8340) using a Teflon-glass Potter-Elvehjem B homogenizer. Samples were centrifuged 
at 10,000 xg for 15 min, supernatants were collected as membranous fractions, and 
protein concentrations of the homogenates were determined by the Biuret method 
described by Cooper (45) with BSA as a standard in order to establish sample loading 
volume. All samples were then mixed with Laemmli sample buffer, boiled for 5 min, and 
100 ug of total protein were subjected to SDS-PAGE electrophoresis on a 10% resolving 
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gel until the desired molecular weight bands were separated. Thereafter, proteins were 
transferred onto a nitrocellulose (NHE1) or a PVDF (NCX) membrane and incubated at 
room temperature in 5% evaporated milk. The membranes were immunoblotted 
overnight at 4 °C with the following primary antibodies: mouse anti-NHE-1 (BD 
Biosciences, #611774), mouse anti-Actin Ab-5 (BD Biosciences, #612656), rabbit anti-
NCX1 (Millipore, #AB3516P), and rabbit anti-Actin (CellSignal, #4967). Membranes 
were then incubated at room temperature with the following secondary antibodies: HRP-
linked goat anti-mouse Ig (BD Biosciences, #554002) for 2 hr or HRP-linked anti-rabbit 
IgG (CellSignal, #7074) for 1 hr. After detection of NHE1 and NCX, membranes were 
stripped and reprobed for Actin. Proteins were detected with SuperSignal West Pico 
chemiluminescent substrate in a BioRad Chemidoc Station and band density was 
assessed using QuantityOne software.   
 Cytochrome c oxidase. Left ventricular tissue and whole plantaris muscle were 
homogenized in 20 volumes of 50 mM KH2PO4, 0.1 mM EDTA, 0.1% (v/v) Triton X-
100, pH 7.4, centrifuged at 1,500xg for 10 minutes, and the supernatant analyzed. 
Cytochrome c oxidase activity, a marker of mitochondria content, was determined 
polarographically using a Clark-type oxygen electrode as described previously (171). All 
tissue preparation steps were carried out at ice-cold temperatures and the enzyme assay 
run at 25
o
C.  
Statistics. An unpaired Student’s t-test was used to determine significant 
differences between the sedentary and exercise groups.  A significance of p < 0.05 was 
considered significant for all tests.  
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Results. 
Animal characteristics. Animal body weights, heart weights, and heart-to-body 
weight ratios are displayed in Table 1. The exercise training protocol increased the heart 
weight by 7.1% and the heart weight/body weight ratio by 7.2% (P<0.05). There was no 
significant change in body weight from training. The effectiveness of the exercise 
protocol was verified by observing an exercise-induced increase (P<0.05) in cytochrome 
c oxidase activity in the plantaris muscle (100%).  No exercise-induced change was 
observed for heart Cytox (P>0.05), which is typical for this extremely aerobic muscle.  
Heart performance. Hemodynamic data at both the low and high workloads 
provide evidence that the hypertrophy was indeed physiological.  Even when normalized 
for heart weight, hearts from exercised animals performed significantly better (P<0.05) 
for all variables displayed (Table 2).  For example, during the high workload normalized 
cardiac output and external work performed by E was higher than S by 17% and 35%, 
respectively.  The greater work performed by E also resulted in higher VO2 compared to 
S.  However, the energy required to accomplish a given amount of work actually 
decreased in E so that their work efficiency increased.   
NHE1 content. As displayed in Figure 1, myocardial NHE1 content decreased 
38% in exercise vs. sedentary (P<0.001). There was no change in the content of actin, 
which was used as a control for protein loading.  
NCX content. Figure 2 shows that exercise training did not affect NCX protein 
expression within the heart (P=0.50).  
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Discussion. 
 The study of pathological and physiological hypertrophy has resolved different 
mechanisms responsible for the induction of cell growth (39,161). NHE1 overexpression 
has been consistently implicated in the pathological cell growth and diminished function 
of the heart, whereas inhibition of NHE1 has been proven as antihypertrophic and 
cardioprotective (35,40,64). The present paper is the first to investigate the relationship of 
NHE1 protein expression and physiological cardiac hypertrophy. We hypothesized that 
NHE1 would not increase in the exercise-induced hypertrophied heart. The results of the 
present study indicate that not only does myocardial NHE1 content not increase, it 
actually decreases following a five-week exercise protocol (Fig. 1)!  This decrease could 
be a major mechanism by which exercise allows for the anti-remodeling of pathological 
hypertrophy. Additionally, myocardial NHE1 can be modulated by a myriad of factors; 
therefore, its regulation in the normal state versus the pathological state and compared to 
the skeletal muscle during exercise needs to be considered. 
Exercise has been shown to allow for anti-remodeling of pathological hypertrophy 
(82,148); however, the complete mechanisms for this alteration are not fully known. 
Garciarena et al. (82,148) exercise trained spontaneously hypertensive rats (SHR) by 
exercising them 90 min/day, 5 day/wk for 60 days. Exercised SHRs displayed even 
greater hypertrophy compared to control SHRs, yet cardiac performance was 
significantly improved. Understanding that the NCX1 is implicated in hypertrophy due to 
its role in Ca
2+
 dysregulation, they examined its protein expression but found no exercise-
induced alteration, which is consistent with the findings of other investigators (124). The 
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content of NHE1 was not examined. We believe that the exercise-induced 
downregulation of NHE1 could be a predominant mechanism explaining the anti-
remodeling effect of exercise that was overlooked at that time. Our data showing that 
NCX1 protein expression is not altered following exercise (Figure 2) coincides with their 
evidence. Recently, downregulation in NHE1 protein expression has afforded protection 
against pathological hypertrophy. Suppression of NHE1 protein content was shown to 
reverse isoproterenol-induced hypertrophy; chronic inhibition of NHE1 for 7 days 
attenuated the isoproterenol-induced increase in NHE1 transcript and protein content 
(177). Additionally, Kilic et al. displayed the anti-hypertrophic effect of suppressing 
NHE1 protein expression back to control levels using a chimera of C-type natriuretic 
peptide and urodilatin (113). These results support that a downregulation of myocardial 
NHE1 content is cardioprotective and may partly underlie the anti-remodeling effect of 
exercise against pathological hypertrophy.  
In the pathological hypertrophy setting ROS have been shown to at least partially 
mediate the upregulation of NHE1 promoter activity and protein expression (5) and the 
increase in NHE1 activity (92). The increased NHE1 activity is through ROS-induced 
ERK1/2 activation (92). This increase in NHE1 content and activity sets up a vicious 
cycle because the augmented [Na
+
]i causes a further increase in ROS production (115). 
Consistent with this, the antihypertrophic and cardioprotective effects of NHE1 inhibition 
have been attributed to the concomitant decrease in ROS production via a decrease in Na
+
 
influx (100). Therefore, previous findings allow us to examine the mechanistic difference 
regarding mechanisms that stimulate NHE1 content changes between pathological 
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hypertrophy and exercise-induced hypertrophy. First, chronic exercise training decreases 
ROS production from the mitochondria through an adaptation to complex I (189) and 
reduces overall myocyte hydrogen peroxide production (103). Second, exercise-induced 
ERK1/2 phosphorylation declines with the development of physiological hypertrophy, 
suggesting it becomes less sensitive to the stress (97). Third, exercise protocols that are 
sufficiently intense result in an increase in antioxidant capacity (159). We can speculate 
that decreasing two major initiators of NHE1 expression and activation (i.e. ROS and 
ERK1/2 activity) will result in a reduction of these characteristics. Indeed, we have 
shown that exercise training reduces NHE1 expression. 
The sarcolemmal NHE1 helps maintain the intracellular steady-state basal pH 
(~7.25) by extruding an intracellular H
+
 in exchange for an extracellular Na
+
. This pH 
regulating function of NHE1 is severely important when intracellular acidosis occurs in a 
cell and sustained intracellular acidosis is a major regulator of NHE1 (92). Skeletal 
muscle NHE1 content increases in response to relatively intense exercise training and 
thereby helps these cells tolerate the stress of an exercise-induced acid load associated 
with intracellular lactic acid buildup (96,104,105). However, the healthy heart does not 
experience an acid load at high exercise intensities because it functions aerobically and 
without significant lactic acid buildup under all workloads.  Indeed, direct measurement 
of pHi in intact hearts demonstrates that pHi does not change as workload increases (190).  
Thus, our finding that myocardial NHE1 is not increased in the exercise trained animals 
is consistent with the fact that the acid load in the heart does not increase during even 
vigorous exercise.  While a downregulation of NHE1 may affect the maximum capacity 
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of the heart to maintain pH, decreases (or increases) in NHE1 alone do not affect pHi 
under physiological conditions because other transporters also assist with pH regulation 
(98,153).  
The integration of the physiological systems provides a multifaceted environment 
to study cell function. The addition of exercise adds a level of complexity as the whole-
body stress causes a divergence from homeostasis. During exercise and in states of 
pathology, the heart is constantly under non-homeostatic intrinsic and extrinsic control. 
Myocardial NHE1 is stimulated by a variety of extrinsic, neurohumoral stimuli such as 
alpha-adrenergic agonists, Angiotensin-II, Endothelin-1, aldosterone, and atrial 
natriuretic peptide (39). These stimuli accompany the chronic pressure overload 
generated by hypertension and are major players in the cardiomyocyte remodeling 
process associated with heart failure. Interestingly, these stimuli are also increased during 
exercise in an attempt to regulate blood volume and cardiac output; however, these 
compounds return to normal levels shortly after the cessation of exercise (126). Having 
an adequate recovery period between exercise bouts allows the heart to adapt and 
remodel in such a way that it becomes able to better handle and recover from subsequent 
stresses. Exercise also activates the insulin-like growth factor 1-phosphoinositide-3 
kinase pathway, which remains activated for some time after exercise and is considered 
the primary regulator of physiological hypertrophy (130). Whether the exercise-induced 
decline in NHE1 facilitates the development of physiological hypertrophy is worthy of 
further investigation.  
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In summary, we have found that NHE1 is downregulated in exercise-induced 
hypertrophy.  This is a compelling finding because of the widely reported involvement of 
NHE1 upregulation to pathological hypertrophy and vulnerability to cell death. In animal 
models pharmacological suppression of NHE1 has consistently been reported to reverse 
pathological hypertrophy and provide protection against infarction following ischemia-
reperfusion. However in humans, clinical trials have resulted in only modest success and 
some significant detrimental side effects. For example, infarct size was decreased in one 
study but there was a concomitant increase in mortality associated with cerebrovascular 
events (131). These drug therapies have not produced their anticipated outcomes, thereby 
strengthening the rationale to explore alternative approaches that provide 
cardioprotection through NHE1 suppression. The well-known cardioprotective effects of 
exercise coupled with the large decrease in NHE1 observed herein suggests that exercise 
may be a clinically relevant means to lower NHE1 and provide cardioprotection. 
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Table 3.1.  Animal characteristics. 
Group (n) 
Body Wt    
(g) 
Heart Wt 
(mg) 
Heart/Body 
(mg/g) 
Plantaris Cytox 
(μmolO2/min/g) 
Heart Cytox 
(μmolO2/min/g) 
Sedentary (8) 268 ± 6 952 ± 15 3.56 ± 0.01 17.4 ± 1.8 115.6 ± 5.0 
Exercise (9) 267 ± 3 1020 ± 13* 3.82 ± 0.06*  34.7 ± 4.1*  122.4 ± 5.6 
 
Values are means ± SE.  Abbreviations: Cytox, cytochrome c oxidase. *Significantly different 
from Sedentary (P<0.05). 
 
 
 
  
 
 
 
6
1 
Table 3.2.  Heart performance. 
Group (n) 
Cardiac Output 
(ml/min/g) 
Systolic Pressure 
(mmHg)  
CO x SP      
(ml/min/g x 
mmHg)  
VO2 
(µmolO2/min/g)  
Efficiency 
(COxSP/ VO2) 
Low workload  
Sedentary (8) 54.1 ± 2.0 107.3 ± 2.4 5,813 ± 279 12.3 ± 0.4 472 ± 14 
Exercise (9)  67.5 ± 2.0*  116.1 ± 2.1*  7,834 ± 274*  15.3 ± 0.4*  513 ± 10* 
High workload  
Sedentary (8) 37.0 ± 1.6 158.7 ± 6.0 5,930 ± 440 20.3 ± 0.8 289 ± 13 
Exercise (9)  43.1 ± 1.2*  184.1 ± 6.5*  7,986 ± 476*  25.1 ± 0.9*  317 ± 12* 
 
Values are means ± SE. Abbreviations: CO, cardiac output; SP, systolic pressure; VO2, oxygen consumption.  
*Significantly different from Sedentary at same workload (P<0.05). 
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Figure 3.1. Myocardial NHE1 content. 
 
 
 
Figure 3.1. Western blot analysis displaying NHE1 expression in sedentary (S) and exercise 
(E) groups. * E is significantly lower than S (P<0.001). 
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Figure 3.2. Myocardial NCX content.  
 
 
 
Figure 3.2. Western blot analysis displaying NCX expression in sedentary (S) and exercise (E) 
groups. There is no significant difference between groups.  
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Abstract. 
 The myocardial Na+/H+ exchanger-1 (NHE1) plays a major role in regulation of 
intracellular pH and its upregulation has been implicated in increased ischemia-
reperfusion injury and other pathologies. Hydrogen peroxide (H2O2) is a major by-
product of reperfusion and is known to enhance NHE1 activity via ERK1/2 signaling. 
However, neither NHE1 activity nor its regulation by H2O2 has been examined in 
response to exercise. Therefore, we examined the effect of aerobic exercise training on 
intrinsic NHE1 activity, H2O2-mediated activation of NHE1, and H2O2-induced 
phosphorylation of ERK1/2 using isolated adult ventricular myocytes. Adult female 
Sprague-Dawley rats were randomly divided into sedentary (S, n=10) and exercise-
trained (E, n=8) groups. Heart weight:body weight and plantaris cytochrome c oxidase 
activity was significantly greater by 6.8% and 1.9 fold, respectively, in E animals 
compared to S animals. NHE1 activity was determined in cells loaded with the pH 
fluoroprobe BCECF. NHE1 activity was 161% greater in E myocytes compared to S 
myocytes (0.57 ± 0.10 v 1.49 ± 0.18 fmol/min), which is attributed to the 55% greater 
cell volume (22.2 ± 0.6 v 34.3 ± 1.1 pL) and 48% greater buffering capacity (28.79 ± 0.72 
v 42.65 ± 0.79 mM/pH unit) of E cells. Stimulation with H2O2 enhanced NHE1 activity in 
S and E but to a significantly lower level in E myocytes (1.55 v 0.64 fold). As assessed 
by Western blotting, H2O2 stimulation also increased phosphorylation of ERK1/2. There 
was no difference in the density of H2O2-stimulated phosphorylation between S and E; 
however, E myocytes were observed to have significantly less total ERK1/2. No 
difference was observed in either cardiomyocyte NHE1 content or catalase and 
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glutathione peroxidase activity. Our data indicate that aerobic exercise training increases 
NHE1 activity at physiological intracellular pH and weakens the H2O2-mediated 
regulation of NHE1 activity.  
 
Keywords: Na
+
/H
+
 exchanger-1 (NHE1); Extracellular signal-regulated kinase (ERK1/2); 
Aerobic exercise training; Internal pH; Hydrogen peroxide (H2O2) 
 
Introduction. 
 The myocardial sarcolemmal Na
+
/H
+
 exchanger-1 (NHE1) plays a major role in 
regulation of intracellular pH (pHi) by extruding one intracellular H
+
 in exchange for one 
extracellular Na
+
. The upregulation of this protein’s content and/or activity increases 
ischemia-reperfusion (IR) injury and is highly implicated in other pathological states such 
as diabetes, hypertrophy, and hypertension due to its role in Ca
2+
 overload (72). 
Hydrogen peroxide (H2O2) is a major reactive oxygen species produced during 
reperfusion (83) and increases NHE1 activity in a time- and concentration-dependent 
manner in rat cardiomyocytes (185). Enhanced NHE1 activity leads to intracellular Na
+
 
accumulation beyond normal levels, which activates the sarcolemmal Na
+
/Ca
2+
 
exchanger (NCX1) in reverse mode resulting in detrimental Ca
2+
 overload (71). Even low 
levels of H2O2 can enhance NHE1 activity and sensitize the cell to Ca
2+
-induced damage 
(169). On the other hand, inhibition of NHE1 activity or knockout of its content are well 
known to provide protection against IR injury, H2O2-induced apoptosis, and pathological 
hypertrophy in animal models (7,35,64,94,101,195,208). Thus, suppression of NHE1 
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seems to be cardioprotective against the oxidative stress of ischemia-reperfusion. We 
recently reported that aerobic exercise training can lower NHE1 content in the whole 
heart (67). However, the effect of exercise training on NHE1 activity and its regulation 
by H2O2 are unknown.  
 The extracellular signal-regulated kinase 1/2 (ERK1/2) are major regulators of 
NHE1 activity, since ERK1/2 can directly phosphorylate NHE1 on the cytosolic tail (42). 
Additionally, H2O2 stimulation increases phosphorylation of ERK1/2 in a time- and 
concentration-dependent manner that corresponds to H2O2-mediated NHE1 activation 
(185,210); therefore, ERK1/2 are implicated in NHE1’s role in H2O2-induced damage. 
Inhibition of ERK1/2 using the inhibitor U0126 attenuated the typical H2O2-induced 
increase in NHE1 activity in isolated cardiomyocytes (169). Activation of ERK1/2 has 
been reported to be increased for at least 30 min following a single 30 min exercise bout 
in previously sedentary animals (97). These authors also reported that after 12 weeks of 
aerobic exercise training for 1 hr/day at the same speed as the acute exercise bout, 
ERK1/2 phosphorylation was no longer increased immediately after the same 30 min 
exercise bout that produced activation in the sedentary rats and that resting ERK1/2 
phosphorylation levels were not different between sedentary and exercise trained 
animals. The authors concluded that acute exercise-induced activation of ERK1/2 
gradually declines with development of exercise training-induced cardiac hypertrophy 
(97); however, they did not take into account that the exercise bout was less stressful after 
chronic training than the acute bout. Thus, whether ERK1/2 may become less sensitive to 
stress activation following exercise training is still in doubt. Neither H2O2-stimulated 
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ERK1/2 phosphorylation nor ERK1/2 regulation of NHE1 has been examined following 
aerobic exercise training.  Therefore, the present study exercise trained adult rats for 5 
weeks and used isolated ventricular myocytes to examine the effect of exercise on NHE1 
content, intrinsic NHE1 activity, H2O2-mediated activation of NHE1, and H2O2-mediated 
phosphorylation of ERK1/2.  
Methods. 
Animals. Female, 5-mo old, Sprague-Dawley rats were purchased and housed in 
the campus animal facility in an isolated room maintained at 22°C with a 12-hour light-
dark cycle and fed ad libitum with Harlan 2018 Teklad Global 18% Protein Rodent Diet. 
Animals were randomly divided into either a sedentary control (S) (n=14) or exercise 
trained (E) (n=11) group. 
Exercise treatment. Exercise was carried out on a motor-driven treadmill using a 
protocol previously found to result in cardiac hypertrophy and a decrease in NHE1 
content in the whole heart (67). Animals were habituated for 1 week by running for 10 
min/day at 10 m/min up a 6˚ incline. During this week the time and speed was gradually 
increased, so that at the end of the week animals were running for 30 min at 25 m/min 
(70-75% VO2max (31)). Following habituation animals began running in the cold (8˚C) 
to prevent an excessive increase in core temperature and running time was gradually 
increased over the course of one week until the animals were running for 1 hr/day at 25 
m/min. Speed was then gradually increased until it reached 30 m/min and maintained at 
that speed for the final weeks. Exercising rats rested for 24 hrs after the last exercise bout 
to remove acute training effects and then the heart was isolated and perfused as described 
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below. This investigation was approved by the University’s Animal Care and Use 
Committee and conforms to the Guide for the Care and Use of Laboratory Animals 
published by the National Institutes of Health (NIH Publication No. 85–23, Revised 
1996). 
Preparation of isolated myocytes. Myocytes were isolated as described by Xu et 
al. (215). Briefly, rats were anesthetized with an intraperitoneal injection of pentobarbital 
sodium (40 mg/kg body wt). Hearts were removed following a transverse thoracotomy 
and rapidly mounted on a Langendorff apparatus. The heart was perfused at a perfusion 
pressure of 61 mmHg in a non-recirculating mode with Krebs-Henseleit buffer (37°C) 
containing (in mM) 118 NaCl, 4.7 KCl, 1.25 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 24.7 
NaHCO3 and 10 glucose for 5 min to wash-out blood. The buffer was bubbled with 95% 
O2/5% CO2. Then the heart was perfused with Ca-free buffer that contained all of the 
above components except CaCl2. After 5 min of perfusion, collagenase (type II) was 
added to the buffer (0.075%) with 25 μM CaCl2 and the heart was perfused in a 
recirculating mode for ~25 min. The heart was removed from the apparatus and the 
ventricles placed into a beaker containing the Ca-free buffer. The ventricles were agitated 
in a shaking bath (37°C) for 10 min at a rate of 50 cycles/min, which allowed individual 
cells to be released. Additional trituration using a wide-tipped transfer pipette assisted in 
cell dispersion. The released cells were suspended and washed three times in an 
incubation buffer containing all the components of the Ca-free buffer, 1% BSA, 30mM 
HEPES, 60mM taurine, 20mM creatine, and amino acid supplements at 37°C. Cells for 
NHE1 activity were filtered through nylon mesh and plated onto laminin-coated 
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coverslips in 35-mm dishes. Cells for ERK1/2 activation were filtered and resuspended in 
Tyrode’s solution containing (in mM) 135 NaCl, 5.9 KCl, 1.2 MgCl, 11.5 Glucose, and 
11.6 HEPES, pH 7.4. Aliquots of cell suspensions were stored in Tyrode’s at -80°C for 
later measurements of activities of antioxidant enzymes and cytochrome c oxidase. 
Experiments were performed on isolated cells within 4 hr of isolation.  
Preparation of cell lysates for detection of ERK1/2 phosphorylation. Myocytes in 
suspension were incubated in Tyrode’s containing H2O2 at concentrations of 0 (Con), 50, 
100, and 200 μM for 5 min followed by a 10-min washout. Concentrations >200 µM 
were not used since maximum ERK1/2 phosphorylation has been shown to occur at H2O2 
concentrations below 200 µM and then to decrease as H2O2 concentration rises (210). 
The 5-min H2O2 perturbation followed by the 10-min washout simulates the time course 
of free radical insult upon reperfusion following ischemia. The 5-min exposure was used 
since peak ERK1/2 phosphorylation in response to 100 μM has been shown to occur at or 
before 6 min (173,185). The 10-min washout was used since ERK1/2 phosphorylation 
continues to increase following exposure (210). The ERK1/2 kinase inhibitors PD98059 
(10 μM (185)) and U0126 (5 μM (210)) were present with a 100 μM H2O2 exposure to 
determine the extent of H2O2 regulation on ERK1/2. Inhibitor or DMSO was present 10 
min before H2O2 exposure. More than one pharmacological inhibitor was used to display 
ERK1/2’s involvement, because all studies utilizing pharmacological inhibitors are 
subject to potential nonspecific effects. Following perturbation, cells were lysed in ice-
cold buffer containing (in mM) 50 NaCl, 50 NaF, 50 sodium pyrophosphate, 5 EDTA, 5 
EGTA, 2 Na3VO4, 0.5 phenylmethylsulfonyl fluoride, 10 HEPES, pH 7.4, 0.1% Triton 
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X-100, and 10 μg/mL leupeptin. Lysed cells were stored at -80°C. Lysates were thawed, 
sonicated, and centrifuged at 10,000 x g for 30 min at 4°C. Protein concentrations were 
determined on supernatants using the Lowry method and samples were processed for 
immunoblotting. 
Measurement of NHE1 activity. The acetoxy methyl ester of 2’-7’-bis(2-
carboxyethyl)-5(6)-carboxyfluorescein (BCECF-AM) was used to measure intracellular 
pH on a Varian Cary Eclipse fluorescence spectrophotometer. BCECF-AM (1.25 μM 
(173)) was used to incubate cells for 15 min at room temp in the dark in Tyrode’s buffer 
supplemented with 0.02% pluronic acid. A coverslip with >80% rod-shaped myocytes 
was inserted into a 4.5-mL optical methacrylate cuvette at a 30° angle to the light beam. 
The solution bathing the cells (pH 7.4) was changed by perfusing fresh solution into the 
bottom of the cuvette while aspirating continuously from just above the coverslip. The 
perfusion rate (7.5 mL/min) was kept constant using a peristaltic pump. At the perfusion 
rate used, the half-time of mixing in the cuvette was ~20 sec. The cells were excited 
alternately at 490- and 440-nm light every 0.02 sec using a rotating excitation filter 
wheel, and average fluorescence intensity ratios (490/440 nm) were recorded at 1.0-sec 
intervals. This technique allowed measurement of pHi that is independent of cell 
concentration and loading. Emission was at 535 nm. At the end of each experiment, the 
fluorescence ratio values were converted to pHi using the nigericin high-K
+
 technique 
(197). This clamps the H
+
 gradient and sets pHi equal to external pH. Cells were perfused 
with high-K
+
 solution containing (in mM) 5 NaCl, 135 KCl, and 50 HEPES at varying 
pH levels (6.8 to 7.8) in the presence of nigericin (4 mg/L). There was a linear 
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relationship between fluorescence intensity ratios and pH over this range (r
2
 = 0.982 ± 
0.002, n = 35).  
Tyrode’s with ammonium chloride (15 mM) was used for 2 min to transiently 
generate an acid load (185). To recover, the cuvette was perfused with a normal Tyrode’s 
buffer (pH 7.4). The cells were then acidified with a second ammonium chloride pulse to 
assess the response to H2O2; the first pulse acted as an internal control. 100 μM H2O2 was 
used as this concentration is a physiologically relevant ROS concentration (83) and was 
also used to determine ERK1/2 phosphorylation (described above). Additionally, the 10-
min H2O2 exposure for NHE1 activity has been previously used (185) and was shown to 
elicit an increase in NHE1 activity in preliminary experiments (data not shown). Cells 
were maintained in HCO3
-
 free medium throughout each experiment, so that the buffering 
capacity could be used as the indicator of NHE1 activity and HCO3
-
/H
+
 exchanger 
activity did not interfere. The NHE1 protein activity was determined by measuring the 
slope of the first linear 20 sec of the recovery period and was expressed as ΔpH/min. The 
change in rate of recovery during the second pulse was normalized to the rate of recovery 
during the first pulse (125). When studying the effects of ERK1/2 on NHE1 activity, the 
second pulse was performed in the presence of PD98059 (10 μM). The inhibitor was 
present 10 min before the start of exposure to H2O2; DMSO was present during the first 
pulse.  
Determination of intrinsic buffering capacity. Intracellular intrinsic buffering 
capacity (B, mmol/liter/pH unit) was determined for each group by stepwise removal of 
extracellular NH4Cl and observing the change of pHi produced by this load. Cells were 
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exposed to Tyrode solution (pH 7.4) containing 20 mM NH4Cl for 90 s, followed by a 
stepwise reduction of extracellular NH4
+
 to 10, 5, 2.5, and 1 mM. At each step calculated 
changes in [NH4
+
]i and measured changes in pHi were used to estimate B, from the 
equation B = ΔNH4 + i/ΔpHi (NH4Clo x 10(pKa – pHi)) / [1 + 10(pKa – pHo)]. The 
Henderson-Hasselbach relation using a pKa for NH4
+
 of 9.21 determined the equilibrium 
between NH4
+
, NH3 and pH in extracellular medium.  
 A volume correction was used to compare proton efflux (JH+) in E and S heart 
cells. The volume factor was determined after fixing cells in phosphate buffered 
glutaraldehyde (1% final concentration) and observing the length and width of 100 cells 
per group (from 3 hearts per group) under a light microscope. The equation V = 
l*w*0.00759 was used to determine cell volume according to Satoh et al. (176), and a 
correction for JH+ (CJH+) was made using the equation CJH+ = d(B*pH*V)/dt. 
Western blotting. Cells used for detecting ERK1/2 were processed for 
immunoblotting as described above (Preparation of cell lysates to determine ERK1/2 
activation). Laemmli’s sample buffer was added to prepare samples for electrophoresis; 
sample volume was based on protein concentration of the sample. Protein concentrations 
of the homogenates were determined by the Lowry method and used to ensure that each 
sample was loaded with the same amount of protein. All samples were subjected to SDS-
PAGE electrophoresis on a resolving gel until the desired molecular weight bands were 
separated. Thereafter, proteins were transferred onto a PVDF membrane, incubated at 
room temp in 5% evaporated milk in Tris buffered saline. The membranes were 
immunoblotted overnight at 4°C with a primary antibody: Anti-NHE1 (Millipore, 
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AB3081), β-Actin (Cell Signaling, 4967), Phospho-p44/42 (Erk1/2, Thr202/Tyr204) 
(Cell Signaling, 9101), or p44/42 MAPK (Erk1/2) (Cell Signaling, 9102). Membranes 
were incubated for 1-2 hr at room temp with a HRP-linked secondary antibody: Anti-
rabbit IgG (Cell Signaling, 7074). Proteins were detected with SuperSignal West Pico 
chemiluminescent substrate in a BioRad Chemidoc Station and densities were measured 
using Quantity One software. The membrane was stripped with a buffer containing (in 
mM) 13.3 Glycine, 3.5 SDS, and 1% Tween-20, pH 2.2. The membrane was reprobed for 
another protein. β-Actin and total ERK1/2 served as loading controls for NHE1 and 
phospho-ERK1/2, respectively. Densities revealed changes in protein expression between 
groups. 
Catalase and glutathione peroxidase (GPx) activity. Because H2O2 was used as 
the stimulus for the aforementioned experiments and crossed the cell membrane into the 
cytosol, the two primary antioxidants that quench H2O2 were examined. Briefly, the cells 
were homogenized on ice in approximately one volume of 50 mM KH2PO4, 0.1 mM 
EDTA, 0.1% (v/v) Triton X-100, pH 7.4. They were then centrifuged at 10,000 x g for 5 
min and the supernatant kept on ice for measurement of the maximum activities of 
catalase, GPx, and cytochrome c oxidase (described later) within 1 hr. GPx activity was 
measured by the method described by Flohe and Gunzler (74). This assay was performed 
at 37°C in a Varian Cary 50 Bio UV-spectrophotometer at a wavelength of 340 nm and 
done in triplicate. Catalase activity was measured polarographically with a Clark-type O2 
electrode at 37°C as described by Abei et al. (2) and done in duplicate.  
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Training status. Whole plantaris muscle and cardiomyocyte suspensions were 
homogenized in ratios of 1:4 w/v or ~1:1 v/v, respectively, in 50 mM KH2PO4, 0.1 mM 
EDTA, 0.1% (v/v) Triton X-100, pH 7.4, centrifuged at 10,000 x g for 5 minutes, and the 
supernatants analyzed. Cytochrome c oxidase (cytox) activity, a marker of mitochondria 
content, was determined polarographically using a Clark-type O2 electrode as described 
previously (171) and done in duplicate. Heart weight:body weight ratio was also used as 
a measure of training. Protein content for all enzyme assays and Western blotting was 
determined by the Lowry method using BSA as the standard. 
Statistical analysis. Factorial ANOVAs or independent t-tests were used to 
uncover main effects. All significance values were set at the α = 0.05 level and, if 
necessary, a Tukey’s HSD was implemented to dissect main effects. For NHE1 protein 
expression and intrinsic NHE1 activity characteristics, an unpaired t-test was used to 
detect differences between groups S and E. For ERK1/2 phosphorylation, a 2x6 factorial 
ANOVA was used; the 2 levels were S and E, while the 6 treatments were H2O2 
concentrations of 0 μM (Con), 50, 100, 200, 100+PD98059, and 100+U0126. For H2O2-
stimulated NHE1 activity, a 2x3 factorial ANOVA was used; the 2 groups were S and E, 
while the 3 treatments were control, 100 μM H2O2, and 100 μM H2O2+PD98059. 
Unpaired t-tests were used to compare cell volume measurements, catalase activity, GPx 
activity, and cytochrome oxidase activity between S and E. 
Results. 
Exercise training adaptations. The animal characteristics of Table 1 display the 
differences between sedentary and exercise trained rats. The exercise training protocol 
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increased both heart weight and body weight in the E group by 11.8% (P < 0.001) and 
5.7% (P < 0.01), respectively. The greater increase in heart weight explains the 
significant increase in heart weight:body weight ratio of 6.8% (P < 0.01). An increase in 
skeletal muscle mitochondrial content, as assessed by cytochrome c oxidase (cytox) 
activity, is a hallmark adaptation of exercise training and plantaris cytox activity was 1.9-
fold higher in E animals (P < 0.001). No exercise-induced change was observed for heart 
cytox (P>0.05), which is typical for this extremely aerobic muscle. Overall, the presence 
of cardiac hypertrophy and the almost 2-fold increase in skeletal muscle mitochondria 
indicate a high state of endurance training. 
NHE1 protein expression. To verify that exercise training does not increase NHE1 
protein content, as shown previously (67), protein density was assessed via 
immunoblotting from isolated adult ventricular myocytes from six animals in both 
groups. No significant difference was detected between S and E (1.87 ± 0.83 vs. 1.47 ± 
0.37 Arbitrary Units, P = 0.25). 
Estimation of cell volume. The cell volume characteristics of sedentary and 
exercise trained myocytes are presented in Table 2. Cell volume was 55% greater in E 
myocytes (P < 0.01), a result of both greater cell length and width. The estimated 
volumes of sedentary adult myocytes are comparable to previously reported values (93). 
The respective cell volume data for S and E were used to calculate the corrected rates of 
proton efflux in the two groups.  
Intrinsic buffering capacity. As depicted in Figure 1, a marked difference existed 
between the intrinsic buffering capacity of S and E myocytes. The best-fit line equations 
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developed following NH4Cl titration were -27.976x + 229.18 and 15.747x - 70.395 for S 
and E, respectively, indicating a 48% greater buffering capacity in exercise-trained 
myocytes at pHi during recovery (~7.16). As pHi decreases, the difference in buffering 
capacity becomes less and less until at pHi 6.8, B is virtually identical between groups.  
NHE1 activity. As shown in Table 3, there was no between-group difference 
regarding the rate of pH change and the minimum pH reached following the NH4Cl 
pulse. The E group had a 48% greater buffering capacity at these pH values compared to 
S (P < 0.001). Buffering capacity at at the pHi in the middle of recovery was used to 
determine rate of proton efflux (JH+). Because all experiments were carried out in the 
absence of HCO3
-
, JH+ could be used as a direct index of sarcolemmal NHE1 activity. 
The JH+ was significantly greater in E compared to S (P < 0.05). Taking into account cell 
volume changes, the final difference, CJH+, was observed to be a 161% increase in NHE1 
activity in rat cardiomyocytes from E hearts (P < 0.001). These results suggest that the 
increase in NHE1 activity observed in E myocytes is a factor of their greater buffering 
capacity and cell volume.  
Influence of H2O2 on NHE1 activity. Figure 2 displays the response of NHE1 
activity to 100 μM H2O2 stimulation. Both S and E NHE1 activity were significantly 
increased upon H2O2 stimulation relative to control values (P < 0.05, n ≥ 7 experiments, 
with cells from ≥ 7 hearts); however, the increase in E myocytes was significantly lower 
than S myocytes (P < 0.05). In both groups, the response to 100 μM H2O2 was abolished 
in the presence of the ERK kinase inhibitor PD98059, supporting ERKs role as a 
mediator of the H2O2-induced increase in NHE1 activity.  
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Effect of H2O2 on ERK phosphorylation. Total ERK1/2 and amount of 
phosphorylated ERK1/2 are displayed in Figure 3. Experiments using a range of H2O2 
concentrations from 50 to 200 μM verified that maximum phosphorylation was achieved 
with 100 μM H2O2 in both groups. The expression of total ERK1/2 was significantly 
reduced in E by 30% for ERK1 and 43% for ERK2 compared to S (P < 0.05, n = 30, each 
H2O2 treatment from 5 different hearts). However, the amount of phosphorylated ERK1/2 
both in the basal state (control) and following stimulation by H2O2 was not significantly 
different between groups. The observations that total ERK1/2 are lower in E than S, yet 
activated ERK1/2 are similar in both groups, indicate that a greater proportion of total 
ERK1/2 is phosphorylated in E compared to S. Both inhibitors (U0126 and PD98059) 
reduced phosphorylation to values not different compared to control values.  
Effect of exercise training on antioxidant activity. The results for catalase and 
GPx are displayed in Table 4. No significant difference was observed between S and E 
groups for either catalase (P = 0.09) or glutathione peroxidase (P = 0.10). This suggests 
that both S and E cells received the same intracellular H2O2 perturbation.  
Discussion. 
 The present study is the first to determine the impact of aerobic exercise training 
on myocardial NHE1 activity. There were two major findings. First, we observed that the 
exercise program used herein resulted in a significant increase in the intrinsic capacity for 
proton efflux from cardiomyocytes via NHE1 at physiological pHi compared to those 
from sedentary animals. Second, the exercise program led to a significant decrease in the 
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sensitivity of NHE1 activity changes in response to ROS signaling pathways. These 
findings will now be discussed. 
Exercise increases intrinsic NHE1 activity. NHE1 activity was measured in intact, 
isolated cardiomyocytes so that intracellular vs extracellular pH differences could be set 
to produce maximum activity, at pH levels where NHE1 activity typically is quiescent 
(205), and the rate of proton efflux across the sarcolemma, i.e., activity, could be directly 
determined. Because our experiments were performed in HCO3
-
-free medium, any 
recovery from NH4Cl-induced intracellular acidosis is from the contribution of NHE1 
(93). E myocytes had a 161% greater CJH+ compared to S myocytes (Table 3). This 
difference can be at least partially explained by the increased buffering capacity (Fig. 1) 
and cell volume (Table 2) detected in E cells. The enhanced buffering capacity is likely a 
reflection of the change in intracellular protein composition in response to training (for 
example, myofilaments), as intracellular buffers are believed to include H
+
-titratable 
groups (16,19). When accounting for the larger cell volume of E myocytes, proton efflux 
increased by another ~96% relative to S myocytes.  
Importantly, the increase in cellular NHE1 activity is not due to an increase in the 
expression of the protein compared to total myocyte proteins. We previously observed 
that the exercise training protocol used for this study resulted in a decrease in NHE1 
content in whole heart (67). In the present study we observed a trend for a decrease in 
NHE1 in isolated ventricular myocytes, but it was not significant at the 0.05 level. Data 
using whole heart tissue sometimes can be difficult to generalize to the heart cell, because 
a heterogeneous population of cells, such as fibroblasts, smooth muscle and endothelial 
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cells, may contribute to the expression. In fact, NHE1 is the predominant pHi regulator in 
fibroblasts (84), smooth muscle and endothelial cells (17). The fact that no change in 
NHE1 protein content was observed at the myocyte level suggests that any between-
group difference in pHi regulation is a direct result of NHE1 activity changes.  
Most exercise-induced adaptations typically inherently present an understandable 
physiological reason for why the alteration occurred. What is the purpose of this 
increased activity? Wisloff et al. (214) exercise trained adult rats on the treadmill for 4 
weeks and examined pHi changes in response to increasing stimulation frequencies 
between 2 and 10 Hz. They observed that at ≥5 Hz both groups acquired acidotic pHi; 
however, exercised cells had significantly less acidosis compared to sedentary cells. The 
increased NHE1 activity observed in our E cells can largely explain the attenuated 
acidosis observed with increasing stimulation frequency. This mechanism also could help 
explain why the trained myocytes displayed enhanced contractility and shorter systolic 
relative cell length compared to untrained myocytes at the same frequencies (214); the 
increased NHE1 activity would result in less H
+
s being present to interfere with Ca
2+
 
binding to Troponin C (14). Although NHE1 is the predominant H
+
 extruding transporter, 
Na
+
-coupled Cl
-
/HCO3
-
 exchange and Na
+
-HCO3
-
 cotransport warrant investigation to 
more fully understand how the exercise trained heart improves its ability to regulate pHi 
during faster pacing (i.e. exercise) (153).  
The NHE1 activity measured herein was carried out at or near physiological pHi, 
since the extracellular pH was constant at pH 7.4 and the lowest pHi reached was ~7.05. 
Using only a physiological pH range is a limitation of this study because pHi can reach 
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considerably lower levels during pathological situations. However, we can speculate on 
exercise-induced NHE1 activity changes outside this pH range using the buffering 
capacity equations presented above. At pHi 6.3, a level possible during 15 min of no-flow 
ischemia (149), E myocytes would have 45% lower B capacity. Following, the CJH+ 
would be ~10% lower in E myocytes compared to S myocytes, which hypothetically 
would be protective against downstream cytosolic Ca
2+
 overload. Moreover, slower 
recovery from pHi would result in lower pHi values, which have been shown to be 
protective against mitochondria permeability transition pore opening (87). Further 
investigation examining NHE1 activity in exercise-trained myocytes at levels more 
comparable to those reached during ischemia are warranted and would provide more 
detailed insight into the role NHE1 plays in the exercise-induced cardioprotective 
phenotype. Also, investigating how exercise-trained myocyte buffering capacity 
decreases with decreasing pHi, possibly by other H
+
-extruding mechanism, is needed.  
Exercise decreases sensitivity of NHE1 activity to ROS signaling pathways. H2O2 
has been implicated previously in increasing NHE1 activity in both neonate (173) and 
adult (185) heart cells. In many pathological situations, including ischemia-reperfusion, 
NHE1 activity is upregulated by ROS generated from the stress. Thus, we examined 
changes in NHE1 activity in response to H2O2, which is a major by-product of 
reperfusion following an ischemic insult. We observed that addition of 100 μM H2O2 
provided 10 min before recovery from the second NH4Cl pulse increased NHE1 activity 
in both sedentary and exercise trained cells, as anticipated based on previous results 
(185); however, exercised myocytes had an attenuated response compared to sedentary. 
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Lower NHE1 activity in response to H2O2 during an ischemic insult (and possibly 
acidosis, as noted above), would be protective because it would result in less cytosolic 
Na
+
 accumulation, which would result in less cytosolic Ca
2+
 overload (195). In addition, 
it would slow pHi recovery, which would inhibit mitochondria permeability transition 
pore opening (87). Interestingly, if the increase in CJH+ in response to H2O2 stimulation is 
viewed in light of the intrinsic CJH+ of each respective group, then activity appears to be 
equal at ~0.92 fmol/min. This then would suggest that NHE1 may not be an exercise-
induced protective mechanism by which cytosolic Ca
2+
 overload is slowed at 
physiological pHi under H2O2 stimulation. The decreased response by the E group could 
be a result of a lower NHE1 protein content, a decreased H2O2 concentration observed by 
the cell due to increased antioxidant capacity, or altered signaling responsible for 
mediating the H2O2 induction of NHE1 activity. As noted earlier, there was no change in 
cardiocyte NHE1 protein content, meaning it likely is not a contributor to the altered 
response. Therefore, the other two possibilities will now be discussed.  
 H2O2 can be quenched by catalase and glutathione peroxidase. Catalase reduces 
H2O2 to H2O and O2, while GPx reduces H2O2 to H2O. The literature is inconsistent 
regarding whether or not these antioxidants change following exercise training. We 
observed both catalase and GPx were not different between exercise and sedentary 
animals at the 0.05 level. These results are similar to other studies that did not detect 
changes in these antioxidants (22,56,57,90,103,164,189). Therefore, it appears that the 
attenuated response of NHE1 activity to H2O2 is not a result of lower perceived H2O2 
concentration.  
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ERK1/2 are major regulators of NHE1 activity since they can phosphorylate 
NHE1 on its cytosolic tail (42). Iemitsu et al. (97) suggested that ERK1/2 may become 
less sensitive to stress activation following exercise training based on their findings that 
endurance trained rats had less ERK1/2 activation following an exercise bout compared 
to previously sedentary rats subjected to the same exercise bout. However, when we 
provided identical H2O2 stresses to cells from S and E we observed similar amounts of 
phosphorylated ERK1/2. Since there was lower total ERK1/2 in E, there was actually 
greater activation in E by the H2O2 stimulation. This suggests that ERK1/2 is more 
sensitive to stress activation by exercise training. This is in direct contrast to the 
conclusions of Iemitsu et al. (97). Their results are likely due to the fact that the trained 
animals experienced less stress during the exercise bout because of training-induced 
adaptations.  
Previous studies focusing on the relationship of ERK1/2 activation and NHE1 
activation in rat cardiomyocytes used sedentary animals (185,210). They reported that 
H2O2 stimulation increases phosphorylation of ERK1/2 in a manner that corresponds to 
H2O2-induced NHE1 activation. An important finding in the present study is that the 
signaling between ERK1/2 and NHE1 is dampened by exercise training. Although we 
observed that a 100 μM H2O2 stress resulted similar amounts of phosphorylated ERK1/2 
in S and E (Fig. 3), there was less NHE1 activation in E (Fig. 2). Thus, NHE1 activation 
becomes less responsive to activated ERK1/2 following endurance training. Although we 
do not have an explanation for this dampening effect due to exercise, it clearly deserves 
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further investigation (i.e. phosphorylation of NHE1 cytosolic tail) because of the 
implications to the effect of enhanced cardioprotection.  
Summary. This was the first study to examine the characteristics of sarcolemmal 
NHE1 activity and signaling in exercise-trained adult rat ventricular cardiomyocytes 
under basal and H2O2-stimulated conditions. We observed that NHE1 activity is 
increased in E myocytes compared to S myocytes at near physiological pHi. This increase 
in activity is a result of enhanced buffering capacity and increased cell volume in E 
myocytes. Additionally, 100 μM H2O2 stimulation increased NHE1 activity in both 
groups; however, to a significantly lower activity level in E cells. The smaller increase in 
NHE1 activity was attributed to altered signaling between ER1/2 and NHE1. These 
results shed light on pHi regulation during exercise and create a starting point for 
examining NHE1 as part of the exercise-induced cardioprotective phenotype.  
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Table 4.1. Animal characteristics. 
 
   Group Body Wt          
(g) 
Heart Wt  
(mg) 
Heart Wt:   
Body Wt  
(mg/g) 
Plantaris Cytox 
(nmol/mg) 
Heart Cytox 
(nmol/mg) 
S 
246.5 ± 2.2  
(15) 
860 ± 14  
(15) 
3.49 ± 0.05  
(15) 
322.0 ± 17.5  
(8) 
1767 ± 139 
(9) 
E 
261.4 ± 3.3* 
(11) 
975 ± 22┼ 
(11) 
3.73 ± 0.08* 
(11) 
608.8 ± 41.3┼ 
(8) 
1457 ± 104 
(9) 
Values are means ± SEM (n). S, sedentary group; E, exercise trained group; Cytox, 
cytochrome c oxidase (nmol O2 consumed/min/mg pro). *P<0.01, 
┼P<0.001 vs. S animals. 
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Table 4.2. Cell volume characteristics. 
 
 
Group Length (μm) Width (μm) Volume (pL) 
S 109.6 ± 1.8 26.7 ± 0.6 22.2 ± 0.6 
E 131.5 ± 2.4* 34.5 ± 0.9* 34.3 ± 1.1* 
Volume = width x length x 0.00759 pL/μm
2
 (176). An n = 
100 cells from 3 hearts was used for each group. The 
estimated S volumes compare to previously reported values 
(93). Values are represented as mean ± SEM. *P<0.01 vs. S 
animals. 
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Table 4.3. NHE1 activity changes. 
 
   S (n=16) E (n=15) 
CJH+(fmol/min) 0.57 ± 0.10 1.49 ± 0.18* 
JH+(mM/min) 0.026 ± 0.004 0.043 ± 0.005** 
B (mM/pH unit) 28.79 ± 0.72 42.65 ± 0.79* 
dpH/min 0.0533 ± 0.0088 0.0607 ± 0.0072 
min pH 7.10 ± 0.01 7.07 ± 0.02 
Pooled data from the first NH4Cl pulse between control and H2O2 
treatments to examine intrinsic characteristics of NHE1 between the two 
groups. S, sedentary group; E, exercise trained group. B, buffering 
capacity; dpH/min, rate of pHi recovery. Values are represented as mean 
± SEM. **P<0.05, *P<0.001 vs. S animals. 
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Table 4.4. Antioxidant levels. 
 
 Group Catalase  
(Unit/mg) 
GSH 
Peroxidase 
(nmol/min/mg) 
S (n=10) 16.19 ± 0.92 25.77 ± 3.64 
E (n=9) 19.41 ± 1.56 33.88 ± 2.83 
Values are means ± SEM. S, sedentary group; E, 
exercise trained group; Catalase (Unit/mg 
protein, where 1 Unit = 1 umol H2O2 
consumed/min); GSH Peroxidase, glutathione 
peroxidase (nmol NADH consumed/min/mg 
protein).   
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Figure 4.1. Intrinsic buffering capacity. 
 
Figure 4.1. Dependency of intrinsic buffering capacity on pHi in sedentary (light boxes) and 
exercise trained (dark boxes) ventricular myocytes based on the calculated equations 
following titrations with NH4Cl. Sedentary: y = -27.98(x) + 229.18; Exercise trained: y = 
15.75(x) + -70.40.  
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Figure 4.2. H2O2-mediated NHE1 activity. 
  
 
Figure 4.2. Effects of 100 μM H2O2 on NHE1 activity and the effects of ERK1/2 inhibition on 
H2O2-induced increase in NHE1 activity. Cells were subjected to two consecutive acid pulses. 
The change in proton efflux (ΔCJH+) during the second acid pulse relative to the first is shown 
in cells exposed to vehicle or 100 μM H2O2 from 10 min before the second acid pulse, in the 
absence or presence of PD98059 (10 μM) pre-treatment. Sedentary is light grey; Exercise 
trained is dark grey. *P<0.05 versus control, ┼P<0.05 versus S H2O2 (≥7 experiments, with 
cells from ≥7 hearts).  
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Figure 4.3. H2O2-mediated ERK1/2 phosphorylation. 
 
 
 
Figure 4.3. ERK1/2 phosphorylation was increased following exposure to H2O2; 
however, a concentration-dependent increase was not observed. Inhibition with 
ERK kinase inhibitors attenuated ERK1/2 phosphorylation to levels not different 
from controls for both groups. S is light grey columns and E is dark grey columns. 
Representative bands are displayed below. Con, control; U, U0126; PD, PD98059. 
*P < 0.05 vs. S control; ┼P < 0.05 vs. E control. The inset displays total ERK1/2 
density differences between S and E. E total ERK2 was significantly lower than S. 
AU, Arbitrary Units. *P < 0.05 vs. S (n = 5 hearts from each group). 
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CHAPTER V 
 
GENERAL DISCUSSION 
 
 
 The primary purposes of this dissertation were to examine the effect of exercise 
training on myocardial NHE1 content, activity, and regulation, and the implication of 
changes to these characteristics. We initially observed that NHE1 content was decreased 
by 38% in the whole heart following exercise training (Chapter III). Because previous 
literature shows that suppression of NHE1 content and/or activity is protective against 
many stresses, especially ischemia-reperfusion and ROS, we hypothesized that this 
exercise-induced decrease in NHE1 content would present as a major mechanism of the 
exercise-induced cardioprotective phenotype. However, to gain a clearer picture of 
NHE1’s potential in the exercise-induced phenotype, NHE1 activity and its regulation 
needed to be studied in response to exercise training. Chapter IV is the first study to 
determine the impact of aerobic exercise training on myocardial NHE1 activity and its 
regulation in the presence of ROS. The two major findings include: 1) the exercise 
program resulted in a significant increase in the intrinsic capacity for proton efflux from 
cardiomyocytes via NHE1 at physiological pHi compared to those from sedentary 
animals, and 2) the exercise program led to a significant decrease in the sensitivity of 
NHE1 activity changes in response to ROS signaling pathways. The increased NHE1 
activity was a result of enhanced buffering capacity and greater cell volume in the 
exercise-trained myocytes. Although, we observed ROS signaling to be not different
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 between groups, there was diminished NHE1 activation in the exercise-trained group 
following ROS stimulation. We do not have an explanation for this dampening
 effect due to exercise, but it clearly deserves further investigation because of the 
potential implications of the effect to enhanced cardioprotection. 
 The implications of altered NHE1 activity include increased or decreased 
intracellular Ca
2+
 and caspase-3 activation. After observing an exercise-induced decrease 
in NHE1 content, we hypothesized that exercise-trained myocytes would have less Ca
2+
 
overload and caspase-3 activation compared to sedentary myocytes. This hypothesis was 
based on the fact that inhibition of NHE1 activity or knockout of its content provides 
protection against ischemia-reperfusion injury. We found that neither Ca
2+
 nor caspase-3 
activity were altered in S and E following H2O2 stimulation and there was no between-
group difference (P > 0.05), as depicted in Figure 1 and Figure 2, respectively. These 
results make sense since there was no significant decrease in NHE1 content in the 
isolated cells as discussed in Chapter IV; however, the diminished response of NHE1 
activity to H2O2 stimulation suggests that NHE1 still may be protective. To that end, the 
equal Ca
2+
 and caspase-3 activity response may be due to the increased intrinsic NHE1 
activity offsetting the decrease in response to ERK1/2-mediated H2O2 stimulation. A 
decrease in NHE1 activity would decrease Ca
2+
 overload and caspase-3 activity in a 
manner similar to a decrease in NHE1 content. Extrapolating the buffering capacity 
results in Chapter IV to pHi values typically reached during ischemia-reperfusion 
suggests that NHE1 activity would be decreased at those pHi values and, thus, protective. 
Therefore, further investigation of Ca
2+
 levels and caspase-3 activity at pHi values 
 
94 
 
observed during ischemia-reperfusion are warranted and would provide more detailed 
insight of NHE1 as an exercise-induced cardioprotective mechanism. Due to high 
variability in caspase-3 activity measurements on the luminometer, an inability to detect 
caspase-3 cleavage via Western blotting, and various misfortunes using the microscope, 
the story is incomplete.  
 Future directions of this project include observing NHE1 activity in myocytes at 
pHi more representative of that obtained during ischemia-reperfusion, examining other 
pHi-regulating mechanisms of the heart cell following exercise, and using NMR in 
combination with an isolated, working-heart model to assess real time Na
+
, H
+
, Ca
2+
 
changes following an ischemic insult. Using a true ischemia-reperfusion model on the 
whole heart or other IR-like models on isolated cells will extend the protective 
characteristics of NHE1. Additionally, examining a dose response between H2O2 and 
ERK1/2 phosphorylation at lower H2O2 concentrations than those used herein will help 
further characterize any exercise-induced effect on ERK1/2 signaling. Further 
investigation of NHE1 in the exercised heart is warranted, because mechanisms that 
regulate pHi in the myocyte are not well studied and the cardioprotective potential of 
NHE1 is so well documented.  
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Figure 5.1. Cytosolic Ca
2+
. 
 
Figure 5.1. The effect of exercise-training induced changes to NHE1 on cytosolic 
Ca
2+
 content in the presence or absence of 100 μM H2O2. S control (light, short 
dash); S H2O2 (light, long dash); E control (dark, short dash); E H2O2 (dark, short 
dash). There were no between-group differences.  
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Figure 5.2. Caspase-3 activity. 
 
Figure 5.2. The effect of exercise-training induced changes to NHE1 on caspase-
3 activity in the presence or absence of 100 μM H2O2. S is light grey and E is 
dark grey. There were no between-group differences.  
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APPENDIX A 
 
OUTLINE FOR STUDY PROCEDURE 
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APPENDIX B 
 
ANIMAL USE 
 
 
Description of use. During the duration of this project, approximately 30 animals were 
utilized. Animals were purchased at 4 months of age and evaluated approximately 3-7 weeks after 
arrival. Exercise trained rats were run on a motorized treadmill for 5 weeks in the temperature 
controlled, all-purpose room of Stone. Rats were run in the 8C room for the final 4 weeks of the 
protocol. On the day of experiment, rats were transported from their housing room in Stone 126 
to the laboratory of Dr. Joseph W. Starnes in Eberhart 215. Experiments were 24 hours following 
the last exercise bout. In Dr. Starnes' lab the animals were anesthetized with an intraperitoneal 
injection of sodium pentobarbital at 40 mg/kg body weight, which prevented any conscious 
response during surgery. The heart was then excised from the anesthetized animal, the heart cells 
were isolated, and all experiments carried out on the isolated heart cells. 
Justification of use. Exercise consistently provides protection to the heart following a bout 
of ischemia-reperfusion. This exercise-induced beneficial adaptation may be at least partially 
responsible for the increased survivability of heart attacks reported in physically active humans 
and the decreased risk of having a heart attack during physical activity in people who regularly 
exercise. Many intrinsic mechanisms have been studied; however, the Na+/H+ exchanger-1 
(NHE1) has not been examined. NHE1 is a sarcolemmal protein implicated in intracellular pH 
regulation. Increases in this protein’s content or activity result in greater damage to the heart and 
heart cell following ischemia-reperfusion; however, inhibition of NHE1 activity or removal of its 
content consistently provides protection against heart attack injury. Thus, suppression of NHE1 
seems cardioprotective. We have previously used the same strain, gender, age of rat to show that 
5 weeks of exercise treadmill training results in a 38% decrease in NHE1 content. However, how 
this exercise-induced decreased affects heart attack injury or how it plays a role in exercise-
induced cardioprotection is not known. Therefore, the overall specific aim of this research project 
was to determine the role NHE1 in the attenuation of H2O2-induced injury. Finding ways to 
protect the heart during ischemic episodes is important as the occurrence of these episodes may 
lead to myocardial infarction, which is the leading cause of death in the United States. Human 
subjects are inappropriate because the end-point of the experiments requires that the heart be 
damaged. Non-animal species are inappropriate because they do not have a heart that is similar to 
that of a human. The rat is deemed most appropriate because of the prior studies carried out on 
this specie, ease of handling, and expense. 
Information on veterinary care. Animals were housed in a central animal care facility 
under the direction of veterinarian specializing in laboratory animals. The University of North 
Carolina at Greensboro has an animal welfare assurance letter on file with NIH (#A 3706). 
Limited injury and use of anesthetic drugs. There is modest risk of injury while exercising 
on the rodent treadmill. This risk was minimized by first acclimatizing the rats to the treadmill at 
sub-maximum intensities so that stress and fatigue was not a factor. If a rat refused to run, it was 
removed from the study. The only injury experienced by a rat was a cut toenail, and the animal 
was removed from the treadmill and antibiotic cream was administered to the toe area. The rats 
were anesthetized with sodium pentobarbital at a dosage of 40 mg/kg body weight, administered 
intraperitoneally by Bryan Feger, who has been trained in this procedure by Dr. Joseph Starnes, 
who has been routinely carrying out this procedure since 1976. 
Method of euthanasia. Removing the heart from the anesthetized animal produced a 
euthanizing effect. This method is consistent with the recommendations of the Panel on 
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Euthanasia of the American Veterinary Medical Association. Dead animals were placed in the 
morgue freezer located in the Animal Care Facility in Eberhart. 
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APPENDIX C 
 
EXERCISE PROTOCOL 
 
 
Week 1 – at room temperature 
Day 1 – 15 min at 15 m/min at 6% grade 
Day 2 – 25 min at 20 m/min 
Day 3 – 25 min at 20 m/min; 5 min at 25 m/min 
Day 4 – 20 min at 20 m/min; 10 min at 25 m/min 
Day 5 – 15 min at 20 m/min; 15 min at 25 m/min 
Week 2 – at 8°C, refrigerated room 
Day 6 – 20 min at 20 m/min; 10 min at 25 m/min 
Day 7 – 30 min at 25 m/min 
Day 8 – 35 min at 25 m/min 
Day 9 – 40 min at 25 m/min 
Day 10 – 45 min at 25 m/min 
Week 3 – at 8°C, refrigerated room 
Day 11 – 50 min at 25 m/min 
Day 12 – 55 min at 25 m/min 
Day 13 – 60 min at 25 m/min 
Day 14 – 60 min at 26 m/min 
Day 15 – 60 min at 27 m/min 
Week 4 – at 8°C, refrigerated room 
Day 16 – 60 min at 28 m/min 
Day 17 – 60 min at 29 m/min 
Day 18 – 60 min at 30 m/min 
Day 19 – 60 min at 30 m/min 
Day 20 – 60 min at 30 m/min 
Week 5 – at 8°C, refrigerated room 
Day 21 – 60 min at 30 m/min 
Day 22 – 60 min at 30 m/min 
Day 23 – 60 min at 30 m/min 
Day 24 – 60 min at 30 m/min 
Day 25 – 60 min at 30 m/min 
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APPENDIX D 
 
HEART CELL ISOLATION 
 
 
Solutions: 
 Krebs-Heinslet buffer (KHB), stock (10x), 1L 
  KH2PO4 1.62 g 
  KCl  3.54 g 
  NaCl  69.24 g 
   Dissolve in 1 L dH2O 
   Store at RT 
 KHB, working solution, 400 mL 
  KHB Stock  40 mL 
  ddH2O   360 mL 
  MgSO4 (0.48 M) 1 mL  
Glucose  0.72 g 
  NaHCO3  0.83 g 
  Taurine   1 g 
   Make fresh daily 
 Incubation buffer, 1 L 
  KHB Stock    100 mL 
  BME amino acids   20 mL 
  MEM non-essential amino acids  10 mL 
  BME vitamin solution   10 mL 
  MgSO4 (0.48 M) 2.5 mL 
 HEPES  7.15 g 
  Taurine   7.5 g 
  Creatine   2.62 g 
  NaHCO3  2.08 g 
  Glucose  1.8 g 
   Dissolve in 1 L dH2O 
   Aliquot into 50 mL conical tubes 
   Store at -20°C 
 500 mM CaCl2 
 250 mM CaCl2 
 1 and 2 N HCl 
 
Procedure:  
1. Turn on circulating water through perfusion system at 37°C, pH meter, and shaking water 
bath at 37°C.  
2. Thaw 1 tube of incubation buffer in shaking water bath. 
3. Prepare KHB working solution; add NaHCO3 first. 
4. Put spin bar in cylinder and stir on stir plate until solutes are dissolved. Be careful to 
make sure all NaHCO3 is dissolved. Remember to bring to 400 mL.  
5. Measure 0.5 g BSA in 50 mL Erlenmeyer flask. 
6. Measure 100 mg collagenase type II and place in 20 mL beaker. 
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7. Put 1 more 50 mL Erlenmeyer and 1 more 20 mL beaker at work station. 
8. Filter KHB solution using vaccum filter and 0.2 um, 47 mm circular filters.  
9. Pour KHB solution into 400 mL Erlenmeyer flask.  
10. Pour 150 mL into a graduated cylinder and oxygenate. 
11. Add 375 uL of 500 mM CaCl2 (1.25 mM) to graduated cylinder.  
12. Add Ca-free KHB to left reservoir and Ca-containing to right reservoir.  
13. Place bubblers in both reservoirs, and the pH electrode in the Ca-free. 
14. Fill Langendorff tubing with necessary solutions. Be careful to make sure there are no air 
bubbles in the lines, and set-up bubble trap.  
15. Anesthetize rat with intraperitoneal injection of ~0.3 mL of 50 mg/mL Na-pentobarbitol.  
16. Make sure there is cold saline in small cup for heart isolation.  
17. When asleep, weigh rat on balance and record weight.  
18. Cut rat transversally below diaphragm and inject inferior vena cava with 0.1 mL heparin. 
Get saline in cup to tare.  
19. Cut up both sides of the rib cage and cut the aorta to excise the heart. 
20. Blot outside of heart with tissue and place in tared saline to get the weight of the heart. 
Record the weight.  
21. With a slow drip, quickly mount the heart onto the canula and clip with gator clip, and 
quickly open flow to the heart with Ca-containing solution.  
22. Tie aorta to canula with thread, cut pulmonary artery, and move drip reservoir to 
surround heart.  
23. After 5 min of Ca-containing solution, switch flow to Ca-free solution.  
24. Dissolve 100 mg collagenase type II in 10 mL Ca-free solution. 
25. When the Ca-free buffer falls to the 100 mL line, add the 10 mL collagenase solution to 
the reservoir with the 12 or 20 mL syringe and 0.45 mm filter, and reduce amount of 
bubbling to attenuate foam buildup.  
26. After 1.5 min, close drip reservoir to start recirculating collagenase solution. During 
recirculation, the collagenase reservoir must constantly be titrated with  2N HCl to keep 
the pH at ~7.4. Add drop of HCl on top of bubbles, so that it will disperse more evenly. 
27. Dissolve BSA in incubation buffer; pour 50 mL of buffer into Erlenmeyer and place 
Erlenmeyer into water bath. 
28. Watch for the heart to swell and become very soft. After ~20-30 min, the flow from the 
heart will increase markedly. When this happens, allow ~10 mL to drip into a 100 mL 
beaker and pH to 7.4. 
29. Remove left atrium, cut ventricles from heart and place in the 100 mL beaker with 
collagenase (from step 27). Stop flow through canula to save buffer.  
30. Mince ventricles into 6 pieces and place beaker in shaking water bath. Allow to shake at 
50 rpm.  
31. Collect ~50 mL of collagenase and pH to 7.4 with 1 N HCl. Add ~35-40 mL of this 
solution to the beaker containing the ventricles.  
32. Add the pH electrode and stick bubbler to the 100 mL beaker with ventricles. Be careful 
to keep pH at ~7.4, but only use 1N HCl; usually 1 drop at pH 7.6 will work.  
33. After 5 min, gently swirl and shake the beaker with ventricles. Use wide-tipped plastic 
transfer pipette to agitate the tissue and disperse the cells. Triturate the tissue 10 times. 
After 5 more min, repeat. Then, perform a 7-10 min trituration. Be gentle! Remember to 
keep watch of pH changes following trituration. If there is still enough tissue, continue to 
triturate it in incubation buffer, while the already dispersed cells settle in the digestion 
buffer. 
 
120 
 
34. Filter cells through mosquito netting into a 50 mL conical tube.  
35. Allow cells to settle for 5 min. 
36. Check pH of incubation buffer, and then remove supernatant from filtered cells, and add 
~20 mL of incubation buffer.  
37. Gently rock tube to re-suspend cells, and allow to settle for ~5 min.  
38. Remove supernatant, add ~15 mL of incubation buffer. 
39. Gently rock tube to re-suspend cells, and allow to settle for ~5 min.  
40. Remove supernatant, add 10 mL of incubation buffer if adding calcium back to cells. If 
not, then add needed amount of Ca-free Tyrodes to cells, filter, and use. 
41. With 10 mL of cells, place these cells in a 50 mL Erlenmeyer and place in water bath. To 
these cells add 250mL CaCl2 every 5 min to gradually restore Ca
2+
 concentration to 1 
mM: 4, 4, 4, 8, 10, 10 uL.   
 
42. After adding last calcium addition, add 7 mL of 1 mM Ca incubation buffer and filter 
cells. Ca-containing cells then can be settled, supernatant removed, and resuspended in 1 
mM Tyrodes (Appendix G – Intracellular Ca
2+
).  
43. Ca-free cells can be plated onto laminin-coated coverslips (Appendix E – NHE1 Activity) 
or left in suspension.  
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APPENDIX E 
 
NHE1 ACTIVITY 
 
 
Solutions: 
 Tyrodes stocks 
  NaCl   4.5 M  1000 mL 
  KCl   1.54 M  500 mL 
  HEPES, pH 7.5  0.386 M  500 mL 
  Glucose  1.15 M  500 mL 
  MgCl2   0.240 M 500 mL 
 Ca-free Tyrodes, 1L 
  NaCl  30 mL  135 mM 
  KCl  3.83 mL  5.9 mM 
  HEPES  30 mL  11.6 mM 
  Glucose 10 mL  11.5 mM 
  MgCl2  5 mL  1.2 mM 
   Bring to 1 L with dH2O 
   Check for pH 7.4 
 Laminin stock, 50 ug/mL 
  Laminin, 1 mg (Sigma, L2020) 
  add 1 mg to 20 mL of Tyrodes 
   Store aliquots at -20°C; keep usable in 4°C 
 BCECF-AM stock, 5.625 mM 
  BCECF-AM, 1 mg (Invitrogen, B1150) 
  220 uL of DMSO into 1 mg vial 
   Store aliquots at -20°C 
 Pluronic F127 stock 
  Pluronic F127 (Invitrogen P6866) 
 NH4Cl stock, 500 mM 
  2.675 g NH4Cl into 100 mL ddH2O 
   Store at 4°C 
 PD98059 stock, 20 mM 
  PD98059, 5 mg (Sigma, P215) 
  900 uL of DMSO into 5 mg vial 
   Store aliquots at -20°C 
 DMSO stock 
  DMSO (Calbiochem, 317275) 
H2O2 stock, 10 mM 
  1.13 mL from 882 mM stock (in 4°C) into 100 mL 
   Store at 4°C 
 Nigericin stock, 2 mg/mL 
  Nigericin, 10 mg, (Invitrogen, N1495) 
  Dissolve 10 mg in 5 mL of ethanol 
   Store at -20°C 
Standards, 100 mL 
  NaCl  5 mM 
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  KCl  130 mM 
  HEPES  50 mM 
   pH 6.8, 7.3, 7.8 
 Solution-making guide 
 
The inhibitor is the most complex; the others simply need to make sure an aliquot 
is used for NH4Cl pulse.  
 
Procedure: 
   Before isolation 
1. Place 2 coverslips (Thomas Scientific, 6663-F10, 11x22, #1) side-by-side in a 35-mm 
culture dish (Corning, 430588, non-treated). 
2. Add 80 uL of Laminin stock to each coverslip; use pipette tip to spread.  
3. Set out all solutions so they can warm to room temperature.  
   Post isolation 
4. Transfer 3 mL of cells to each culture dish.  
5. Allow 30 min for cells to settle. 
6. Using transfer pipette, slowly remove supernatant with floating cells and add back 2 mL 
of normal Tyrodes.  
7. Allow 30 min for cells to equilibrate.  
8. Add 1.1 uL of BCECF-AM stock and 1.0 uL of Pluronic F127 to 5 mL of Tyrodes in a 
15-mL conical tube.  
9. Decant Tyrodes from dish, and add 2.5 mL of BCECF-AM Tyrodes; place remaining 2.5 
mL back in drawer to keep in dark.  
10. Put dish on shaker underneath box top (to keep dark), and rock at tilt 2 for 15 min.  
11. While cells are incubating, turn on computer and fluorometer. Set-up software as 
described under Software Setup.  
12. Load perfusion line (into fluorometer) with appropriate solution; fill three cuvettes each 
with 2.5 mL of one standard; put cuvette with 2.5 mL of Tyrodes and cuvette holder by 
workstation.  
13. After 15 min of loading, decant BCECF-AM Tyrodes and add fresh Tyrodes. Allow 15 
min in dark (under box top) for probe to de-esterify.  
14. Grab coverslip with adhered cells using skinny tweezers and place into cuvette holder; 
have cells facing the excitation light beam.  
15. Place cuvette into single-cell holder of fluorometer with cells facing excitation light 
beam, and slowly insert perfusion system into cuvette; the in-flow tip should be on the 
side of the coverslip with no cells.  
16. Start Ratio software program.  
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17. Turn on in-flow pump; only flip toggle because the flow rate is set. Turn on out-flow 
pump at a speed higher than in-flow.  
18. When the run is complete, add 5 uL of Nigericin to each standard, pause the software, 
place the coverslip into a standard and read for ~30 seconds. Repeat for remaining 
standards. 
   Software Setup 
Click on Setup button 
 Cary tab 
  Instrument setup:  Data mode  Fluorescence 
  Wavelength setup: Collection type  Excitation fast filter 
     Em. Wavelength (nm)  535 
  Collect timing:  Simple collect  filled 
     Ave time (s)  1 
     Stop (min)  55 
 Options tab 
  Emmission filter  Auto 
 Accessories tab 
   Fast Filter 
  Fast filter:  Result 1  Check (Filter 3/Filter 1) 
  Filter 1: Name  BCECF Wavelength  440 
  Filter 3: Name  BCECF Wavelength  490 
 Analyze tab 
  Nothing 
 Reports tab 
  X-Y Pairs table  Check 
 Auto-store tab 
  Storage: On; prompt at end  filled 
  Auto-convert: ASCII (csv)  filled 
Click OK for instrument to set itself 
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APPENDIX F 
 
ERK1/2 PHOSPHORYLATION 
 
 
Solutions: 
 Tyrodes stocks 
  NaCl   4.5 M  1000 mL 
  KCl   1.54 M  500 mL 
  HEPES, pH 7.5  0.386 M  500 mL 
  Glucose  1.15 M  500 mL 
  MgCl2   0.240 M 500 mL 
 Ca-free Tyrodes, 1L 
  NaCl  30 mL  135 mM 
  KCl  3.83 mL 5.9 mM 
  HEPES  30 mL  11.6 mM 
  Glucose 10 mL  11.5 mM 
  MgCl2  5 mL  1.2 mM 
   Bring to 1 L with dH2O; Check for pH 7.4 
U0126 stock, 10 mM 
 U0126, 1 mg (Sigma, U120-1MG) 
 234 uL of DMSO into 1 mg vial 
  Store at 4°C 
PD98059 stock, 20 mM 
  PD98059, 5 mg (Sigma, P215) 
  900 uL of DMSO into 5 mg vial 
   Store aliquots at -20°C 
H2O2 stock, 10 mM 
  1.13 mL from 882 mM stock into 100 mL 
   Store at 4°C 
 DMSO stock 
  DMSO (Calbiochem, 317275) 
 Lysis Buffer 
  NaCl   50 mM 
  NaF   50 mM 
  Na pyrophosphate 50 mM 
  EDTA   5 mM 
  EGTA   5 mM 
  Na3VO4  3 mM 
  phenylmethylsulfonyl Fl, 0.5 mM 
  HEPES   10 mM 
  Triton X-100  0.1 % 
  Leupeptin  10 ug/mL 
   Store at 4°C 
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Procedure: 
1. Aliquot 3 mL of Ca-free cells into each treatment conical tube.  
2. Add 1.5 uL of DMSO, PD98059, or U0126 to cells; in doing multiple it is necessary to 
add with 1-2 min between each addition.  
3. Keep tube on side for 10 min.  
4. Add 30 uL of H2O2 stock to the 3 mL of cells, if necessary.  
5. Put tube upright so cells can settle during 5 min perturbation.  
6. Decant supernatant and add fresh, H2O2-free Tyrodes.  
7. Keep tube on side for 5 min; turn tube upright for final 5 min so cells can settle. 
8. Decant supernatant, add 100 uL of cold Lysis Buffer, and put in -80°C freezer. 
9. Upon thawing for Western blotting (Appendix G), vortex for 10 seconds, spin at 10,000 
xg at 4°C for 30 min, and keep supernatant for protein determination (via Lowry, 
Appendix I).  
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APPENDIX G 
 
INTRACELLULAR Ca
2+
 
 
 
Solutions: 
 Tyrodes stocks 
  NaCl   4.5 M  1000 mL 
  KCl/CaCl2  1.18/0.3 M 500 mL 
  HEPES, pH 7.5  0.386 M   500 mL 
  Glucose  1.15 M  500 mL 
  MgCl2   0.240 M 500 mL 
 Ca-containing Tyrodes, 1L 
  NaCl  30 mL  135 mM 
  KCl/CaCl2 5 mL  5.9/1.5 mM 
  HEPES  30 mL  11.6 mM 
  Glucose 10 mL  11.5 mM 
  MgCl2  5 mL  1.2 mM 
   Bring to 1 L with dH2O 
   Check for pH 7.4 
Fluo 4-AM stock, 4 mM 
 Add 11.4 uL of DMSO to 50 ug 
  Store at -20°C 
Rhod 2-AM stock, 4 mM 
 Add 11.1 uL of DMSO to 50 ug 
  Store at -20°C 
EIPA stock, 10 mM 
 EIPA, 25 mg (Sigma, A3085) 
 8.3 mL of DMSO into 25 mg vial 
  Store at 4°C 
Pluronic F127 stock 
  Pluronic F127 (Invitrogen P6866) 
H2O2 stock, 10 mM 
  1.13 mL from 882 mM stock into 100 mL 
   Store at 4°C 
 DMSO stock 
  DMSO (Calbiochem, 317275) 
Procedures: 
   Before microscopy 
1. To 3 mL of Ca-containing Tyrodes, add 1.5 uL of Fluo 4-AM stock (for cytosolic), 3 uL 
of Rhod 2-AM (for mitochondrial), and 1.5 uL of Pluronic F127. Add this to 3 mL of 
cells. 
2. Let cells incubate for 30 min in dark at room temperature on rocker; have cells settle in 
remaining 5 min of incubation period.  
3. Remove supernatant and add 2 mL of fresh Tyrodes.  
4. Plate 200 uL of cells to the coverslip bottom of the culture dish.  
5. Allow 30 min for cells to settle (or drive to JSN).  
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6. Add 2 mL of Tyrodes to dish and subsequently remove to wash off any floating cells; 
then add 2 mL of Tyrodes back to dish.  
   Microscopy of cells 
7. Turn on computer and microscope using the numbers and associated power buttons. 
8. Open the AxioVision software. 
9. Place dish onto microscope stage and make sure it is secure; add tape to back of dish.  
10. In Acquisition, turn on FITC and RHOD (widefield view) to observe cells and find  
11. Once cells are found, turn on FITC SD and RHOD SD (spinning disk) and Measure for 
exposure time. Find the best plane for fastest exposure time (i.e. milliseconds).  
12. Set time and number of exposures.  
13. Add EIPA or DMSO and begin recording.  
14. Add H2O2 when necessary.  
15. To remove the H2O2-treated media and add fresh Tyrodes, quickly push back lens head 
and use transfer pipettes to change media. Be very careful not to move the dish or add 
media back so harshly that cells wash off. Then, quickly and carefully re-set lens head for 
next image to be taken.  
16. Save images so data can be analyzed later with Image J.  
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APPENDIX H 
 
CASPASE-3 ACTIVITY 
 
 
Solutions: 
 Tyrodes stocks 
  NaCl   4.5 M  1000 mL 
  KCl/CaCl2  1.18/0.3M 500 mL 
  HEPES, pH 7.5  0.386 M   500 mL 
  Glucose  1.15 M   500 mL 
  MgCl2   0.240 M 500 mL 
 Ca-containing Tyrodes, 1L 
  NaCl  30 mL  135 mM 
  KCl/CaCl2 5 mL   5.9/1.5 mM 
  HEPES  30 mL  11.6 mM 
  Glucose 10 mL  11.5 mM 
  MgCl2  5 mL  1.2 mM 
   Bring to 1 L with dH2O; Check for pH 7.4 
EIPA stock, 10 mM 
 EIPA, 25 mg (Sigma, A3085) 
 8.3 mL of DMSO into 25 mg vial 
  Store at 4°C 
H2O2 stock, 10 mM 
  1.13 mL from 882 mM stock into 100 mL 
   Store at 4°C 
 DMSO stock 
  DMSO (Calbiochem, 317275) 
Lysis Buffer 
  NaCl   50 mM 
  NaF   50 mM 
  Na pyrophosphate 50 mM 
  EDTA   5 mM 
  EGTA   5 mM 
  Na3VO4  3 mM 
  phenylmethylsulfonyl Fl, 0.5 mM 
  HEPES   10 mM 
  Triton X-100  0.1 % 
  Leupeptin  10 ug/mL 
   Store at 4°C 
Procedures: 
1. Aliquot 3 mL of Ca-containing cells into 15-mL conical tube.  
2. Add 1.5 uL of DMSO or EIPA to cells; in doing multiple it is necessary to add with 1-2 
min between each addition.  
3. Keep tube on side for 10 min.  
4. Add 30 uL of H2O2 stock to the 3 mL of cells, if necessary.  
5. Put tube upright so cells can settle during 5 min perturbation.  
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6. Decant supernatant and add 500 uL of fresh, H2O2-free Tyrodes (w/DMSO or EIPA).  
7. Keep tube on side for 10 min.  
8. Add reagents from Promega Caspase-3/7 Glo Assay in equal portions – 90 uL.  
9. Aliquot 90 uL, 3X from one tube into a 96-well plate. And follow directions from 
manufacturer. 
10. Put conical tube upright so remaining cells can settle. 
11. Decant supernatant, add 50 uL of cold Lysis Buffer, and put in -80°C freezer. 
12. Upon thawing for Western blotting (Appendix G), vortex for 10 seconds, spin at 10,000 
xg at 4°C for 30 min, and keep supernatant for protein determination (via Lowry, 
Appendix I).  
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APPENDIX I 
 
LOWRY’S METHOD FOR DETERMINING PROTEIN CONCENTRATION 
 
 
Solutions: 
Protein Standard 
 For 10 mL of 1 mg/mL stock: 
10 mg Bovine Serum Albumin (Sigma, A-4378) in dH2O 
Solution A, 2 L 
40 g Na2CO3, 8 g NaOH, and 0.4 g NaK tartrate in dH2O 
Store in dark 
Solution B, 1 L 
5 g CuSO4, 5H2O in dH2O  
Store in dark 
Solution C 
50 parts Solution A to 1 part Solution B  
Prepare fresh 
Folin Ciocalteau’s Phenol Reagent (Sigma, F-9252) 
Dilute 5 parts of reagent with 6 parts dH2O. 
Procedure: 
1. Standard Curve 
Prepare duplicate samples in the following manner: 
[mg/mL] 1 mg/mL BSA stock (l) dH2O (l) Final Volume (l) 
0.00 0 500 500 
0.03 15 485 500 
0.06 30 470 500 
0.09 45 455 500 
0.12 60 440 500 
0.15 75 425 500 
0.18 90 410 500 
0.21 105 395 500 
* note concentrations at 0.18 and 0.21 mg/mL are probably out of range make sure std 
curve does not begin to level off if using these concentrations. 
2. Experimental Samples, Each sample is done in duplicate. Add 490 l of dH2O, 10 l of 
sample, and 2.5 mL of Solution C. 
3. Initiation of reaction and reading, add 0.5 mL of diluted Folin Ciocalteau’s Phenol 
Reagent to each sample and vortex. Incubate at room temperature for 30 minutes, with 
timing starting upon the first addition of the reagent. Read O.D. at 660 nm. 
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APPENDIX J 
 
WESTERN BLOTTING – SDS-PAGE 
 
Solutions: 
30% Acrylamide/Bis Solution, 29:1 
 Stock solution (Bio-Rad, 161-0156) 
1.5 M Trizma 
45.42 g Trizma Base in 250 mL dH2O, pH 8.8 
1.0 M Trizma 
30.29 g Trizma Base in 250 mL dH2O, pH 6.8 
20% SDS (sodium dodecyl sulfate) 
Stock solution (Bio-Rad, 161-0418) 
TEMED 
Stock solution of N, N, N’, N’ - tetramethylethylenediamine (Sigma, 87689) 
Ammonium Persulfate (APS) 
 For 1 mL of 10% 
100 mg APS in dH2O  
Prepare fresh daily 
10X Running Buffer, 1 L 
Trizma   30.28 g 
Glycine  144.2 g 
in dH2O 
1X Running Buffer, 1 L 
10X Running Buffer 100 mL 
20 % SDS  5 mL 
in dH2O 
β-Mercaptoethanol 
 Stock from Fisher (BP176-100) 
Dithiothreitol (DTT) 
 For 10 mL of 2 M 
3.086 g in dH2O 
4X Sample Buffer 
 4X Final 1X Concentration 
1.25 M Trizma, pH 6.8 10 mL 62.5 mM 
Glycerol 20 mL 10.0% 
20% SDS 10 mL 1.0% 
bromophenol blue 0.008 g 0.004% 
ddH2O 5 mL  
To use sample buffer, add 100 l of β-Mercaptoethanol (or 2 M DTT) 
 to 900 L of 4X sample buffer. 
Then use 1:3 with sample (i.e. 80 uL sample with 20 uL buffer). 
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Resolving Gel, 2 gels 
10 % 12 % 8 % 
30% Acrylamide/Bis 3.3 Ml 4.0  2.7 
1.5 M Tris, pH 8.8 2.5 mL 2.5  2.5 
ddH2O 4.0 mL 3.3  4.6 
20 % SDS 100 uL 100  100 
10 % APS** 100 uL 100  100 
TEMED** 4.0 uL 4.0  6.0 
** immediately prior to casting 
Stacking Gel, 2 gels 
5% 
30 % Acrylamide/Bis 1.7 mL 
1.0 M Tris, pH 6.8 1.25 mL 
ddH2O   6.8 mL 
20 % SDS  100 uL 
10 % APS**  100 uL 
TEMED**  10 uL 
**immediately prior to casting 
Procedure: 
1. Assemble gel apparatus according to manufacturer’s instructions in casting stand. 
Prepare resolving gel solution for number of gels to be cast in 15 mL conical tube. 
2. Gently swirl solution and then use a Pasteur transfer pipette to fill caster 3/4 full – up to 
black mark. Overlay resolving gel with 200 l of butanol and allow gel to polymerize. 
3. Pour butanol off the resolving gel and rinse with dH2O. 
4. Prepare stacking gel solution for the number of gels cast, gently swirl solution, pour on 
top of the resolving gel and insert Teflon comb while avoiding bubbles. Allow 1 hour for 
polymerization. 
5. While the stacking gel is polymerizing prepare samples. Samples that were homogenized 
1:10 in homogenization buffer are further diluted 1:3 with 4X sample buffer, vortexed for 
10 seconds, and allowed to incubate 20 min at room temperature. (Samples that were 
prepared through affinity chromatography will have been prepared in 1X sample buffer.) 
Place samples in boiling water for 5 min prior to loading to help SDS coat proteins. 
6. Following polymerization of the stacking gel, assemble the gel apparatus for 
electrophoresis and place in the electrophoresis chamber. Fill the inner chamber with 
running buffer and bring the outer chamber to 1/4 full with running buffer. 
7. Use yellow loading guide to load protein samples based on Lowry-determined protein 
concentrations and appropriate amounts of standard. Electrophorese at a constant 50 mA 
per 2 gels and a maximum of 200 V and 200 W until the tracking dye runs off the gel. 
8. Following electrophoresis, remove clamping frame from mini tank and pour off Running 
Buffer. Remove gel cassette sandwiches from clamping frame. Separate glass plates 
using green wedge. Discard stacking gels. Carefully mark an edge of the resolving gel for 
orientation. 
9.  Carefully place resolving gels into Transfer Buffer.  
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APPENDIX K 
 
WESTERN BLOTTING – WET TRANSFER 
 
 
Solutions:  
 Transfer Buffer, 1 L 
  Trizma  3.03 g 
  Glycine  14.4 g 
  Methanol 200 mL 
  20 % SDS 2 mL 
   in dH2O 
*SDS for proteins that are hard to elute from gel, like larger proteins; but 
SDS not needed for smaller proteins that elute easily 
10X TBS (Tris buffered saline), 1 L 
Tris 24.23 g 
NaCl 80.06 g 
pH 7.4 in dH2O 
1X TBS (TBS), 1 L  
10X TBS 100 mL 
in dH2O 
 Blocking Solution, 100 mL 
  Dry Milk 5 g 
  TBS  100 mL 
   stir, filter with cheesecloth, 50 mL/membrane 
Procedure: 
1. Soak in Transfer Buffer for 20 min: 2 gels, 4 fiber pads, 4 filter papers, 2 PVDF 
membranes. 
2. Assemble transfer cassettes in the following manner: 
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3. Place gel cassettes in electrode module (align black side of cassette with black side of 
module). 
4. Place ice pack and stir bar in mini tank with electrode module. 
5. Fill mini tank with remaining Transfer Buffer and put on greed lid (with red to red and 
black to black).  
6. Place mini tank on stir plate and begin spinning and transfer: 350 mA (constant), 100 V, 
200 W, 1 hr.  
7. Following transfer, place membranes in blocking solution for 1 hr at room temperature on 
shaker.  
8. Optional, check the gel to see if proteins were eluted and the membrane to see if proteins 
were transferred. Use coomasie blue to stain gel for the proteins. Wash gel 3x5 min with 
water, then 45 min with coomasie blue, then wash 3x5 min with water. The gel can be 
stored in water. Use Ponceau Red to stain membrane. The stain can be stripped with 2% 
v/v acetic acid and water, and does not interfere with immunoblotting.  
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APPENDIX L 
 
WESTERN BLOTTING – IMMUNOBLOTTING 
 
 
Solutions: 
10X TBS (Tris buffered saline), 1 L 
Tris 24.23 g 
NaCl 80.06 g 
pH 7.4 in dH2O 
1X TBS-0.1% Tween (TBST), 1 L  
10X TBS 100 mL 
Tween 20 1 mL 
in dH2O 
Primary antibody (1° Ab) 
Dilute 1° Ab to optimal conc. (Appendix J) in TBST with 5% BSA (10 mL per 
gel). 
Secondary antibody (2° Ab) 
Dilute appropriate HRP-labeled 2° Ab to optimized concentration (Appendix J) 
in TBST in 5% milk (10 mL per gel); dissolve milk in TBST and then filter 
through cheesecloth before adding 2° Ab.  
 SuperSignal solutions 
West Pico Chemiluminescent Substrates: 
 Luminol/Enhancer (Thermo Scientific, 1859675) 
Peroxide Buffer (Thermo Scientific, 1859674) 
 Stripping buffer, 1 L 
  Glycine  15 g 
  SDS  1 % (50 mL of 20 %) 
  Tween 20 10 mL 
   pH 2.2 in dH2O (w/ conc. HCl) 
Procedure: 
1. Block PVDF membranes for 1 hr at room temperature 1X TBS with 5% milk; dissolve 
milk in TBS and then filter through cheesecloth before adding membrane. 
2. Rinse the membranes with two quick washes of TBST. 
3. Incubate membranes with 1° Ab overnight at 4°C on shaker. 
4. Wash 3X5 minutes in TBST. 
5. Incubate membranes with 2° Ab for 1-3 hrs at room temperature on shaker. 
6. Wash 5X5 minutes with TBST. 
7. Prepare the membranes for autoradiography using PIERCE SuperSignal solutions (Pierce 
Chemical, Rockford, IL) according to manufacturer’s instructions; mix 3 mL of each 
solution and pour on membrane; incubate for 5 min. 
8. Turn on computer, Chemidoc, camera.  
9. Open QuantityOne software. 
10. Open scanner from Volumes Quick Guide 
11. Place membranes directly onto surface of Chemidoc, and situate them so that they can be 
seen by the camera using Live Focus. 
12. Freeze the frame and close the door.  
13. Use Live Acquire to obtain image; save images that are desirable. 
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14. When finished, place membranes in TBST for stripping, if necessary (step 18).  
15. Use Volume Rectangular Tool or Volume Contour Tool to obtain density of bands.  
16. Data can be exported to comma delimited format, and then copy/pasted into Excel for 
statistical analysis.  
17. TURN OFF camera and Chemidoc station! 
 
   Stripping of membrane 
18.  Wash membrane in TBST for 5 min. 
19. Incubate membrane in Stripping buffer for 20 min. 
20.  Wash membrane in TBST for 10 min. 
21. Block membrane in TBS with 5% milk, and begin immunoblotting again. 
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APPENDIX M 
 
BLOTTING OPTIMIZATION 
 
 
  
NHE1 NCX β-Actin 
phospho-
ERK1/2 
total 
ERK1/2 
Caspase3 
Molecular 
Weight: 110 kDa 67 kDa 45 kDa 42, 44 kDa 42, 44 kDa 17,35kDa 
Lysis 
Buffer: 
Appendix Appendix Appendix Appendix Appendix Appendix 
Total 
Protein 
Load: 
100 ug 100 ug   30-50 ug   100 ug 
Resolving 
Gel: 10% 10%   10%   10% 
Primary 
Antibody: 
Anti-NHE1 
pAb, Rabbit 
(Millipore, 
AB3081)  
Anti-NCX1 
affinity 
purified 
pAb, Rabbit 
(Millipore, 
AB3516P) 
β-Actin 
pAb, 
Rabbit 
(Cell 
Signaling, 
4967) 
Phospho-p44/42 
MAPK (Erk1/2) 
(Thr202/Tyr204) 
pAb, Rabbit 
(Cell Signaling, 
9101) 
p44/42 
MAPK 
(Erk1/2) 
pAb, Rabbit 
(Cell 
Signaling, 
9102) 
Caspase-
3 pAb, 
Rabbit 
(Cell 
Signaling, 
9662) 
Primary 
Dilution: 
1:360 in 5% 
BSA-TBST  
1:400 in 5% 
BSA-TBST 
1:1000 in 
5% BSA-
TBST 
1:1000 in 5% 
BSA-TBST 
1:500 in 5% 
BSA-TBST 
  
Secondary 
Antibody: 
 Anti-rabbit 
IgG, HRP-
linked Ab 
(Cell 
Signaling, 
7074) 
Anti-rabbit 
IgG, HRP-
linked Ab 
(Cell 
Signaling, 
7074) 
Anti-rabbit 
IgG, HRP-
linked Ab 
(Cell 
Signaling, 
7074) 
Anti-rabbit IgG, 
HRP-linked Ab 
(Cell Signaling, 
7074) 
Anti-rabbit 
IgG, HRP-
linked Ab 
(Cell 
Signaling, 
7074) 
Anti-
rabbit 
IgG, 
HRP-
linked Ab 
(Cell 
Signaling, 
7074) 
Secondary 
Dilution: 
1:1000 in 
5% milk-
TBST 
1:1000 in 
5% milk-
TBST 
1:1000 in 
5% milk-
TBST 
1:1000 in 5% 
milk-TBST 
1:1000 in 5% 
milk-TBST 
1:1000 in 
5% milk-
TBST  
Exposure 
time: 3-5 min 3-5 min 4-6 min 4-6 min 3-5 min   
Comments: Heat sample 
in block at 
55°C; 2 hr 
2°Ab 
incubation  
2 hr for 
2°Ab 
incubation; 
strips fairly 
well 
  strips really 
well; do before 
total ERK1/2 
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APPENDIX N 
 
CATALASE ACTIVITY 
 
 
Sample Preparation: 
1. Pipette 1 mL of tissue homogenate into centrifuge tube. 
2. Centrifuge 1,500 x g for 10 minutes at 4°C, retain supernatant for analysis. 
Solutions: 
Homogenization Buffer 
K2HPO4 50 mM 
EDTA  0.1 mM 
Triton X-100 0.1 % 
 pH 7.4 
H2O2 – Hydrogen Peroxide 
1 M H2O2 stock solution 
Procedure: 
1. Equilibrate the incubation buffer with N2 gas in order to decrease O2 concentration to a 
very low amount so that the O2 produced from the catalase reaction will remain in 
solution during the assay. 
2. Add 1.5 mL nitrogen-equilibrated buffer to the oxygen electrode cuvette. 
3. Add 15 μL of supernatant and obtain baseline oxygen production rate. 
4. Add 15 μL of 1 M H2O2 to initiate the reaction and obtain oxygen production rate. (Final 
concentration of H2O2 = 9.8 mM). 
Calculations: 
Catalase activity in Units/mg heart wet weight.  
Where 1 Unit = 1 μmol H2O2/min 
Net O2 production rate (Step 4 - Step 3) X 2 (as 2 hydrogen peroxides are consumed for 
each oxygen produced) divided by amount of tissue in 15 μL. 
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APPENDIX O 
 
GLUTATHIONE PEROXIDASE (GPx) ACTIVITY 
 
 
Solutions: 
 Potassium phosphate buffer  50 mM 
  with DPTA  0.5 mM 
  pH 7.0 
 NADPH   8 mM 
 Reduced Glutathione (GSH) 0.1 M 
 Glutathione Reductase (GSR) 50 U/mL 
 t-Butyl hydroperoxide (t-BOOH), 30 mM 
Procedure: 
1. Turn on UV-spectrophotometer to allow UV lamp to warm for ~15 min, and the water 
bath recirculator at 37°C for 5 min.  
2. Set up spectrophotometer to read for 3 min at 340 nm.  
3. Add the following to a 1.5 mL cuvette.  
a. 100 uL potassium phosphate buffer 
b. 20.0 uL GSH 
c. 2.0 uL GSR 
d. 26.0 uL NADPH 
4. Add 20 uL of sample homogenate supernatant to cuvette. 
5. Blank the spectrophotometer. 
6. Insert cuvette into cell of spectrophotometer. 
7. Add 20 uL t-BOOH to cuvette to begin reaction. 
8. Mix contents of cuvette by re-pipetting. 
9. Run spectrophotometer.  
10. Record absorbance (OD) change for 3 minutes at 340 nm.  
Calculations:  
 GPx/mg Protein – (OD/minute * total volume * 2) / (6.22 * volume of sample * mg 
protein in cuvette), where: 
 mg protein in cuvette is calculated by Lowry (Appendix I) 
  
This is designated as the total rate of NADPH consumption. The non-enzyme dependent 
consumption of NADPH is also measured as above except that the 5 uL of sample is 
replaced by 5 uL of assay buffer. The rate of enzyme-dependent NADPH consumption is 
obtained by subtracting the non-enzyme-dependent NADPH consumption rate from the 
total NADPH consumption rate. GSH peroxidase activity is calculated using the 
extinction coefficient of 6.22 mM
-1
 cm
-1
, and expressed as nmoles of NADPH 
consumed/min/mg of cellular protein. 
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APPENDIX P 
 
HOMOGENIZATION PROTOCOL FOR TISSUE 
 
 
Solutions: 
Homogenization Buffer 
K2HPO4 50 mM 
EDTA  0.1 mM  
Triton X-100 0.1 % 
 pH 7.4 
Procedure: 
1. Trim approximately 150 mg of left ventricle from frozen heart. 
2. Weigh tissue, and place remaining tissue in -20°C freezer.  
3. Calculate buffer volume as: mass of tissue in grams X 19 = volume in mL of 
homogenization buffer. 
4. Cut tissue into small pieces and place in homogenization tube. 
5. Add volume of buffer from step 3 to homogenization tube, and place on ice. 
6. Insert Teflon wand and start rotation of wand. 
7. Homogenize by making approximately 5 passes of the wand into the tube. 
8. Remove wand and inspect for non-homogenized pieces of tissue to put back in tube.  
9. Repeat passes 2 more times, keeping tube on ice during and between each step. 
10. Strain homogenate through one layer of cheese cloth. 
11. Remove number of aliquots necessary for completion of assays and place remaining 
homogenate in -80°C. 
12. Put tissue in -20°C back into -80°C for later. 
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APPENDIX Q 
 
CYTOCHROME C OXIDASE (CYTOX) ACTIVITY 
 
 
Solutions: 
 Assay medium 
  K2HPO4 50 mM 
  EDTA  0.1 mM 
   pH 7.4 
   Store at 4°C 
 Ascorbate solution 
  TMPD  62 mM 
  Ascorbate 20 mM 
   Store at -20°C, in dark bottle (light sensitive) 
   If solution is not clear, then remake 
 Ascorbate   
Ascorbate 1.25 M  
pH 5.6 
   Store at -20°C in small aliquots 
 Cytochrome c solution 
  cytochrome c 3.92 mM 
  Tris   50 mM 
   pH 7.2 
   0.243 g cytochrome c to 5 mL Tris 
   Store at -20°C 
Procedure: 
1. Before beginning assay, warm needed amount of Assay medium to 37°C. 
2. Assemble stirred, closed cuvette with a Clark-type oxygen electrode and connect to a 
strip chart recorder in a 25C chamber. 
3. Open oxygen electrode cuvette and add: 
a. 1.45 mL Assay medium 
b. 15.0 uL of Ascorbate solution 
c. 15.0 uL of 1.25 M Ascorbate 
d. 15.0 uL of Cytochrome c solution 
4. Close cuvette and record changes in oxygen tension.  
5. Open cuvette and add 30 uL of homogenate supernatant.  
6. Close cuvette and record total rate of oxygen consumption. 
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APPENDIX R 
 
GLOSSARY 
 
 
Adenosine triphosphate (ATP) – The energy molecule of the cell; its phosphate bonds hold 
chemical potential energy that drives the processes of the human body.  
Antioxidant – A substance that can reduce or destroy oxidants. 
Aortic Flow (AF) – The volume of blood flowing through the aorta per minute, normalized for 
the size of the heart in milliliters per minute per gram of heart wet weight. 
Apoptosis – Programmed cell death; the controlled degradation and death of the cell through the 
use of ATP and specific intracellular signaling.  
Calcium overload – a compartmentalized increase in Ca
2+
 concentration above homeostatic levels 
that leads to cellular damage. The compartmentalization is typically seen in either the 
cytosol or the mitochondria.  
Calpains – A group of Ca
2+
-dependent proteins that degrade regulatory proteins within the cell.  
Cardiac Function (COxSP) – An index of external work that an isolated working heart is 
performing during perfusion. Calculated as the product of the cardiac output and peak 
systolic pressure. 
Cardiac Output (CO) – The volume of blood the left ventricle of the heart ejects per minute, 
normalized for the size of the heart. Calculated as the sum of the coronary flow and the 
aortic flow in milliliters per minute per gram of heart wet weight. 
Cardioprotection – Improved intrinsic tolerance of the myocardium to an imposed stress. 
Caspase-3 – An enzyme that degrades proteins, which leads to cell death, and is the effector 
protein of the mitochondrial-mediated cell death pathway.  
Catalase (CAT) – The antioxidant enzyme that catalyzes the conversion of hydrogen peroxide to 
H2O and O2. 
Coronary Flow (CF) – The volume of blood flowing through the coronary vasculature per minute, 
normalized for the size of the heart in milliliters per minute per gram of heart wet weight. 
Dihydropyridine receptor – A membrane-bound channel that allows Ca
2+
 to enter the cell upon 
depoloarization.  
Efficiency – The quotient of cardiac function (COxSP) and oxygen consumption. 
Exercise-induced cardioprotection – The intrinsic protection that acute and/or chronic aerobic 
exercise confers to the heart.  
Free Radicals – A highly reactive class of molecules, categorized by the presence of an unpaired 
electron in the outer orbital. 
Glutathione (GSH) – A tri-peptide with a reduced sulfhydryl group, which is capable of being 
oxidized by glutathione peroxidase during the conversion of hydrogen peroxide to water. 
Glutathione Peroxidase (GPX) – The antioxidant enzyme that catalyzes the conversion of 
hydrogen peroxide to H2O. 
Heart Rate (HR) - The rate at which the heart contracts, in beats per minute. 
Heat Shock Protein 72 (HSP72) – The 72 kilo-Dalton inducible form of a protein in a class of 
proteins called stress proteins, implicated in the facilitation of cardioprotective 
mechanisms. The abbreviation HSP70 represents both the constitutive and inducible form 
of the protein 
Hypertension – A chronic state of high blood pressure that causes damage and remodeling of the 
heart due to the increased workload this situation places on the heart.  
Hyperthermia – An increase in body temperature above normal.  
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Hypertrophy – An increase in the size of the heart. Pathological hypertrophy can result from a 
chronic load to the heart (i.e. hypertension). Physiological hypertrophy is a result of 
normal development or exercise, when intermittent increases in workload are presented to 
the heart.  
Ischemia – Period of no-flow in the myocardium during which the delivery of substrates and the 
removal of metabolic byproducts is prevented. 
Ischemic preconditioning – Protection from heart attack injury that is afforded to the cell after 
receiving short, intermittent bouts of ischemia.  
Isolated Heart Perfusion – Procedure for measuring the function of the heart ex vivo by providing 
artificial blood flow to the heart and allowing the heart to pump independently from the 
organism. 
Krebs-Henseleit Buffer – Solution used to perfuse the hearts containing essential ions and 
substrates at an osmolarity and pH similar to that observed in vivo. 
Lactate Dehydrogenase (LDH) – The enzyme which catalyzes the reversible reaction from 
Lactate to Pyruvate. It is normally located in the cytosol of all cells and its presence in the 
coronary effluent indicates sarcolemma damage, which may lead to cellular necrosis. 
Langendorff Perfusion – Isolated heart perfusion in which the heart does not perform any external 
work, as the heart only contracts against a retrograde perfusion pressure. It is also used to 
perfuse hearts in order to isolate heart cells.  
Lω-Nitro-L-arginine methyl ester hydrochloride (L-NAME) – A competitive inhibitor of all three 
isoforms of nitric oxide synthase. 
Mitochondrial calcium uniporter (MCU) – A mitochondrial-membrane-bound protein that is the 
only way cytosolic Ca
2+
 can enter into the mitochondrial matrix in normal, physiological 
situations.  
N-(2-Mercaptopropionyl)glycine (MPG) – Pharmacological, potent free radical scavenger. 
Myocardium - The heart muscle. 
Myocardial infarction (MI) – Dead heart tissue resulting from a heart attack.  
Nitric Oxide (NO) – A reactive nitrogen species produced by the action of nitric oxide synthase, 
which is responsible for signaling vasodilatation and initiating other cell-signaling events. 
Nitric Oxide Synthase (NOS) – The enzyme that produces nitric oxide during the enzymatic 
conversion of L-arginine to L-citrulline. The three predominant isoforms include: eNOS, 
the endothelial isoform; iNOS, the inducible isoform; and nNOS the neuronal isoform. 
Oxidative Stress – A stress in an organism caused by increased production of free radicals or 
reactive oxygen species, or a decrease in the antioxidant defense system.  
Phospholamban – A protein that inhibits the activity of SERCA.  
Preconditioning – Any treatment capable of triggering a cardioprotective response in the 
myocardium that can protect against subsequent stresses. Preconditioning falls into two 
general categories, the early and late phase. The early phase appears minutes following a 
treatment, and is generally characterized by post-translational modification of existing 
proteins. The late phase occurs anywhere from hours to days following treatment, and is 
generally characterized by de-novo synthesis of proteins. 
Potassium-sensitive ATPase (KATP) – A channel in both the plasma and mitochondrial 
membranes that allows for K
+
 to move through it in response to changes in ATP 
concentration.  
Rate pressure product (RPP) – The product of heart rate and systolic blood pressure; one measure 
of the amount of work a heart is performing.  
Reactive Oxygen Species (ROS) – A class of highly reactive molecules, including free radicals, 
which can cause oxidative stress. 
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Reperfusion – The period following ischemia, after the occlusion is removed, when oxygen is 
provided back to the cell and metabolic by-products are removed. Here is when most of 
the damage to the cell/tissue occurs.  
Sarco-endoplasmic reticulum Ca
2+
 ATPase (SERCA) – A protein on the membrane of the sarco-
endoplasmic reticulum that uses ATP to move Ca
2+
 from the cytosol into the organelle.  
Sodium-calcium exchanger (NCX) – A membrane-bound protein that exchanges one extracellular 
Na
+
 for one intracellular Ca
2+
, which is the forward mode. This protein can act in reverse-
mode, which can lead to calcium overload.  
Sodium-hydrogen exchanger (NHE) – A membrane-bound protein that exchanges one 
extracellular Na
+
 for one intracellular H
+
. The NHE-1 isoform is in the heart.  
Sodium-potassium ATPase (NK ATPase) – A membrane-bound protein that exchanges 2 
extracellular K
+
 for 3 intracellular Na
+
. This protein is the major way the cell re-
establishes the membrane potential.  
Superoxide Dismutase (SOD) – The antioxidant enzyme that catalyzes the conversion of 
superoxide to hydrogen peroxide. The predominant isoforms include: MnSOD, located in 
the mitochondria; and CuZnSOD, located in the cytosol of the cell. 
Systolic Pressure (SP) – The maximum pressure in the aorta during the contraction of the left 
ventricle, measured via the placement of a pressure transducer at the level of the aortic 
valve. 
Tachycardia – A rapid increase in heart rate above normal.  
Transgenic mice – A genetically altered line of mice; in most cases one gene is altered so that the 
effect of that gene at the organ or system level can be determined.  
Tyrode’s Buffer – Solution used to bath heart cells containing essential ions and substrates at an 
osmolarity and pH similar to that observed in vivo. 
Unfolded protein response (UPR) – A cellular stress response related to the endoplasmic 
reticulum; the endoplasmic reticulum typically responds by upregulating protective 
proteins.  
Wild-type mice – The non-genetically altered counterparts of transgenic mice; there is no change 
in any gene in this mice strains.  
Working Heart Perfusion – Isolated heart perfusion in which the heart functions in a 
physiological, recirculating manner while producing measurable external work. 
 
